rfhg_167904.1

Basic information about the TSS

---

TSS ID: rfhg_167904.1 Species: human Chr: chr14		Start: 73097009 End: 73097021 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000532192.1:15 GeneID: 58517 HGNC/MGI_ID: HGNC:23244 UniProt_ID: H0YE46 Nearer transcript ids and distances:

Gene_name: RNA binding motif protein 25 Gene_symbol: RBM25 Gene_synonyms: NET52 S164 Snu71 fSAP94 Gene_source: HGNC:23244

TATA-Box annotation

---

Distance to TSS:	38481
Nearest PromoterID:	NM_021239
Entrez ID:	58517
Nearest Unigene:	Hs.531106
Nearest Refseq:	NM_021239
Nearest Ensembl:	ENSG00000119707
Gene Name:	RNA binding motif protein 25
Gene Alias:	NET52|RED120|RNPC7|S164|Snu71|fSAP94
Gene Type:	protein-coding
CpG%:	0.083333
GC%:	0.230769
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RBM25 p2@RBM25 p3@RBM25 p4@RBM25 p5@RBM25 p7@RBM25 p8@RBM25
Sample		p1@RBM25	p2@RBM25	p3@RBM25	p4@RBM25	p5@RBM25	p7@RBM25	p8@RBM25
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	79.67	54.74	3.90	2.34	4.87	2.14	2.14
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	75.67	54.83	3.84	2.02	5.66	2.43	2.23
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	87.58	59.41	4.05	3.47	6.94	2.51	3.28
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	74.85	49.48	3.95	2.91	3.33	0.83	1.04
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	67.94	53.32	3.15	1.80	2.02	2.92	1.57
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	72.49	41.28	4.65	1.94	4.26	1.55	1.16
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	91.73	49.24	5.45	4.36	3.49	0.44	1.53
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	76.78	48.44	6.06	1.94	2.18	1.21	1.21
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	80.36	40.18	6.20	1.71	2.56	0.43	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	92.16	81.15	1.74	1.74	4.06	1.74	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	91.36	86.10	3.64	2.02	5.26	1.62	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	97.98	76.43	2.03	2.03	2.03	1.63	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	69.15	10.32	3.39	0.64	0.32	0.97	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	64.20	9.02	2.41	1.50	0.60	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	66.96	8.78	1.76	0.88	0.66	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	56.59	7.54	1.01	1.76	0.25	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	50.23	5.24	2.18	0.22	0.22	0.66	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	50.20	6.33	1.27	0.42	0.84	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	66.11	11.20	1.07	1.07	1.07	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	56.87	8.88	2.86	1.96	0.60	0.30	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	58.67	10.56	3.07	0.67	0.27	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	59.21	11.22	2.76	1.55	0.17	0.52	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	55.45	7.63	2.46	1.42	0.13	0.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	40.53	5.58	1.70	1.70	0.73	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	56.50	8.51	3.10	2.32	0.26	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	51.27	10.13	1.58	1.27	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	55.50	10.99	2.75	0.55	1.65	1.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	59.65	13.44	3.06	2.83	0.47	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	55.40	8.72	3.39	0.65	0.32	0.48	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	58.09	7.42	2.53	0.72	0.54	0.36	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	67.41	12.14	4.40	0.63	0.00	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	58.03	8.40	1.56	1.17	0.39	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	43.05	5.70	2.74	0.21	0.21	0.42	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	68.61	11.22	1.98	1.32	0.66	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	54.79	8.79	2.43	1.87	0.00	0.19	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	51.55	9.20	2.49	1.34	0.77	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	59.47	9.81	1.84	1.84	0.00	0.82	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	48.96	9.07	2.42	1.01	0.00	0.40	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	54.56	12.96	2.16	0.27	0.81	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	56.41	12.96	2.40	0.96	0.48	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	49.40	8.23	1.88	1.41	0.71	0.71	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	67.19	11.57	3.66	0.88	0.59	0.44	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	70.86	12.02	2.74	0.84	0.42	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	67.48	10.49	3.85	1.22	0.17	0.17	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	76.49	15.46	3.61	1.00	0.40	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	70.96	10.24	2.79	2.09	0.93	1.16	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	56.14	11.28	1.44	0.48	0.72	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	57.82	14.01	4.47	0.89	0.00	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	70.85	11.97	2.87	0.96	0.24	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	80.68	13.35	2.83	0.40	0.61	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	100.02	18.65	4.71	1.23	0.61	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	110.74	20.68	4.89	1.78	0.44	1.11	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	727.59	279.84	13.99	195.89	97.95	83.95	55.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	77.71	10.29	2.48	1.42	0.71	1.06	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	55.67	12.26	2.32	0.99	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	117.45	31.88	1.68	17.62	11.75	6.71	2.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	114.81	16.07	1.38	1.84	0.46	0.46	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	83.94	14.58	3.24	0.65	0.65	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	65.20	9.96	1.93	0.96	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	121.33	20.43	1.57	2.51	0.94	1.89	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	59.22	7.05	2.82	0.71	0.71	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	58.88	6.17	4.49	0.56	0.56	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	101.11	24.68	0.80	18.31	2.39	1.59	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	120.62	13.59	2.04	3.40	1.02	0.34	1.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	67.58	19.50	1.95	1.30	0.32	0.97	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	42.60	7.10	1.06	0.35	0.35	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	727.38	145.48	0.00	161.64	96.98	32.33	64.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	465.95	157.95	0.00	102.67	23.69	47.38	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	51.19	9.75	1.46	0.49	0.98	0.49	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	58.02	8.43	2.98	0.50	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	50.66	8.44	2.35	0.00	0.00	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	97.37	11.59	1.99	0.33	0.33	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	72.08	7.11	4.02	0.93	0.31	0.31	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	69.40	9.17	3.36	0.31	0.61	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	42.92	6.81	2.06	0.32	0.48	0.32	0.16
Adipocyte - breast, donor2	11327-117E4	23.90	7.22	1.44	1.93	0.80	0.48	0.16
Adipocyte - omental, donor1	11473-119C6	42.49	9.16	1.53	0.38	0.13	0.38	0.00
Adipocyte - omental, donor2	11474-119C7	18.69	5.23	0.75	0.00	0.75	0.75	0.75
Adipocyte - omental, donor3	11475-119C8	19.43	6.03	0.67	0.33	0.67	0.33	0.33
Adipocyte - perirenal, donor1	11476-119C9	17.23	1.91	0.64	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	13.19	1.10	3.30	0.00	1.10	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	29.36	5.87	0.90	0.90	1.35	0.45	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	12.69	2.61	0.70	0.35	0.87	0.70	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	53.59	7.63	2.35	0.39	0.78	0.00	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	49.42	7.46	3.09	0.26	0.00	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	43.77	6.97	2.23	0.00	0.56	0.00	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	58.78	5.88	1.76	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	61.69	17.86	3.22	1.13	0.72	0.48	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	49.06	9.04	1.29	0.00	0.00	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	35.72	6.40	2.67	1.60	0.53	0.00	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	42.29	7.23	2.78	0.56	0.00	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	28.70	5.41	4.57	0.00	0.42	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	29.64	5.78	2.51	0.00	0.25	0.25	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	38.94	6.87	1.64	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	32.27	7.00	0.91	0.61	0.61	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	16.57	3.09	0.88	0.66	0.22	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	11.12	3.94	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	5.99	1.20	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	36.34	6.30	1.62	0.18	0.18	0.54	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	5.02	1.67	1.67	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	14.79	3.90	0.21	0.41	0.21	0.00	0.21
Anulus Pulposus Cell, donor1	11248-116E6	42.80	4.46	0.92	0.92	1.95	0.57	0.80
Anulus Pulposus Cell, donor2	11463-119B5	25.23	2.69	0.98	0.00	1.47	0.49	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	26.96	4.04	0.90	0.90	1.80	0.00	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	27.35	8.68	1.74	2.17	3.04	0.43	1.74
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	29.96	2.14	2.14	0.00	2.14	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	31.39	5.68	0.60	1.79	2.99	1.20	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	27.82	7.59	1.26	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	17.82	4.62	0.66	1.98	1.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	17.87	5.52	0.32	0.65	0.65	0.32	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	30.58	4.37	0.97	0.97	1.94	0.00	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	24.94	2.97	1.78	0.00	3.56	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	24.10	4.90	1.13	1.13	1.13	1.13	1.51
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	26.85	5.08	0.73	2.90	2.90	0.00	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	13.79	1.25	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	27.02	8.40	0.16	0.00	0.49	0.00	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	20.47	2.73	1.36	0.00	1.36	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	21.86	4.98	0.75	0.45	0.45	0.15	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	31.61	5.36	0.54	2.14	1.61	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	20.59	4.72	1.70	0.94	1.89	0.19	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	24.59	6.41	1.60	1.87	1.34	0.53	1.07
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	26.34	4.88	0.00	0.00	0.00	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	23.39	3.81	1.33	0.17	1.16	1.00	0.83
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	25.22	6.00	1.20	0.00	2.40	3.60	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	24.78	3.54	0.00	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	26.93	6.69	1.72	1.03	1.54	1.03	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	29.36	0.00	0.00	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	27.18	7.28	0.97	0.00	2.91	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	29.22	6.07	0.38	1.52	1.14	1.14	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	15.75	3.63	0.00	0.00	2.42	0.00	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	23.37	3.99	0.57	0.57	1.14	0.57	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	23.73	5.56	1.71	1.07	1.71	0.64	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	22.45	3.61	1.55	0.26	0.52	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	18.77	4.69	0.94	1.41	0.47	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	21.54	4.50	0.32	2.25	1.93	1.61	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	19.26	0.00	0.71	0.71	0.71	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	24.57	2.92	0.58	1.17	3.51	0.58	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	26.80	6.02	0.90	0.60	0.60	0.90	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	28.51	0.00	0.00	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	23.39	2.54	1.02	0.00	1.02	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	25.98	5.09	1.53	2.04	2.80	1.02	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	13.98	3.18	1.27	0.00	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	24.60	5.61	0.43	1.29	1.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	20.53	4.66	1.91	1.06	0.64	0.42	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	18.56	3.19	1.74	0.87	1.74	1.16	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	30.23	3.78	0.00	0.94	0.94	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	24.07	4.58	1.19	0.68	1.02	0.17	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	25.48	4.63	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	27.46	2.11	0.00	0.00	0.00	0.00	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	24.44	3.86	1.93	1.07	0.64	0.21	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	21.66	3.01	0.00	1.20	1.20	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	24.06	5.10	2.19	0.73	0.73	0.00	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	26.21	7.13	0.92	0.23	0.46	0.69	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	15.30	7.65	2.55	2.55	2.55	2.55	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	22.12	4.07	0.00	0.00	0.51	0.00	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	25.80	8.46	2.06	0.00	2.48	0.83	1.03
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	19.89	5.20	2.14	0.31	2.14	1.22	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	31.07	4.30	1.91	0.96	1.91	1.91	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	27.50	5.54	0.22	1.55	1.33	0.67	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	16.78	1.53	1.53	1.53	4.58	3.05	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	30.46	9.42	0.00	0.55	0.55	1.11	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	27.80	6.62	1.59	1.59	1.06	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	25.08	6.18	1.82	0.73	1.45	1.82	1.09
Astrocyte - cerebellum, donor1	11500-119F6	32.06	5.77	1.47	0.37	0.61	0.25	0.00
Astrocyte - cerebellum, donor2	11580-120F5	26.19	3.25	1.37	0.00	0.00	0.17	0.00
Astrocyte - cerebellum, donor3	11661-122F5	19.51	1.89	1.26	0.00	0.21	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	89.24	23.01	2.79	2.79	5.58	1.39	1.05
Astrocyte - cerebral cortex, donor2	11316-117D2	84.28	18.93	4.04	4.53	2.59	2.59	2.10
Astrocyte - cerebral cortex, donor3	11392-118C6	77.41	17.90	2.39	2.54	3.58	1.79	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	98.51	30.62	7.80	7.23	6.42	3.44	1.49
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	104.36	37.58	9.27	9.90	7.39	3.88	1.88
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	105.94	34.82	10.92	8.53	8.08	3.30	1.37
Basophils, donor1	12241-129G9	70.09	10.20	4.18	0.26	0.00	0.00	0.00
Basophils, donor2	12242-129H1	212.51	32.83	12.27	0.00	0.00	0.36	0.36
Basophils, donor3	12243-129H2	83.79	12.20	6.76	0.88	0.00	0.44	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	8.84	2.16	0.43	0.22	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	9.60	1.83	0.91	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	7.17	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	22.60	5.02	0.63	0.00	0.63	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	14.35	2.91	0.21	0.00	0.00	0.62	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	11.74	2.30	1.61	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	30.95	5.58	0.90	2.52	3.42	1.62	2.34
Burkitt's lymphoma cell line:DAUDI	10422-106C8	84.51	59.88	3.81	4.53	4.33	4.64	1.24
Burkitt's lymphoma cell line:RAJI	10476-106I8	153.48	54.50	7.92	10.01	6.75	5.82	1.16
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	107.44	23.98	8.95	0.32	1.92	0.32	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	217.18	31.03	0.00	0.00	0.00	10.34	0.00
CD14+ Monocytes, donor1	11224-116B9	180.90	25.36	8.45	1.69	0.00	0.56	1.13
CD14+ Monocytes, donor2	11305-117B9	211.03	32.11	11.51	12.62	1.67	1.30	0.56
CD14+ Monocytes, donor3	11381-118B4	183.31	26.34	10.10	10.76	2.20	1.32	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	75.01	10.76	3.11	0.28	0.57	0.28	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	96.28	10.99	2.65	0.38	0.76	0.76	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	70.02	12.49	2.30	0.66	0.33	0.33	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	70.40	14.74	3.04	4.48	1.01	1.88	0.43
CD14+ monocytes - mock treated, donor2	11873-125C1	104.40	22.33	2.72	3.02	1.21	1.21	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	150.66	27.24	2.84	4.50	0.95	0.47	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	51.89	13.22	2.18	2.51	1.00	1.00	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	72.32	16.84	1.93	4.14	0.28	1.93	1.66
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	99.67	22.31	3.72	3.47	0.99	0.74	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	50.71	12.14	2.94	2.35	1.96	1.57	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	78.52	14.78	3.20	3.56	0.71	0.71	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	118.61	19.80	3.05	1.74	0.65	0.00	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	57.36	11.00	3.75	1.87	0.70	0.47	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	113.53	27.46	2.64	4.75	1.06	0.00	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	94.30	23.30	1.11	2.22	2.22	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	58.76	16.66	2.08	6.25	0.45	1.78	0.89
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	75.83	15.37	1.40	4.39	0.40	0.20	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	90.57	19.36	2.71	1.04	0.62	0.83	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	54.22	18.53	2.97	4.80	2.06	1.83	0.92
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	88.90	16.74	0.90	0.23	0.23	0.45	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	79.00	18.77	3.06	1.31	1.31	1.75	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	70.48	16.14	2.96	1.61	1.88	0.81	1.08
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	98.22	16.22	2.79	7.33	1.74	0.52	0.70
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	143.50	23.15	5.05	2.95	0.84	2.10	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	47.21	10.84	2.57	4.96	1.65	1.84	0.55
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	81.02	16.91	1.06	2.47	0.35	1.41	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	101.78	20.18	2.19	1.75	0.00	0.44	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	57.89	15.17	4.01	6.45	1.92	1.05	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	89.20	13.38	4.83	7.43	1.12	1.12	1.12
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	132.13	29.75	4.96	1.08	1.08	0.43	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	58.56	11.47	2.87	0.82	1.64	1.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	82.29	20.40	2.55	0.46	0.23	0.46	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	93.26	22.04	3.25	0.46	1.62	0.70	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	95.90	14.82	3.71	0.44	0.87	0.65	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	106.72	10.16	5.08	0.92	1.85	0.46	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	105.49	9.75	2.38	0.65	0.65	0.00	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	131.59	17.75	5.45	2.34	0.78	0.62	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	141.29	11.88	4.02	1.22	1.57	0.17	1.22
CD14+CD16- Monocytes, donor3	11910-125G2	298.78	24.53	5.13	2.68	1.34	1.34	1.11
CD14-CD16+ Monocytes, donor1	11790-124B8	78.85	7.40	5.61	0.00	0.26	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	119.66	10.32	5.27	0.88	0.88	0.22	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	126.33	9.90	3.58	0.63	0.84	0.21	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	105.68	10.16	8.13	0.00	2.03	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	143.73	16.27	2.71	2.03	0.68	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	152.23	18.64	2.07	1.04	0.00	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	146.05	23.99	1.60	0.00	2.67	1.07	1.60
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	137.23	19.83	2.14	1.61	1.07	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	129.86	19.65	1.40	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	133.34	18.04	0.78	0.00	1.57	0.78	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	150.28	26.37	2.64	1.32	3.95	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	240.82	42.74	9.86	9.86	1.64	3.29	0.00
CD19+ B Cells, donor2	11624-122B4	297.43	41.35	10.88	2.18	0.73	2.90	0.73
CD19+ B Cells, donor3	11705-123B4	310.47	37.36	12.12	5.05	3.03	2.02	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	263.04	32.73	6.87	0.40	4.04	2.83	2.83
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	161.39	19.97	5.59	0.40	3.99	1.20	0.80
CD34+ Progenitors, donor1	11545-120B6	110.45	15.06	7.03	1.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	175.85	42.70	10.11	1.12	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	95.44	29.31	4.51	1.13	1.50	0.38	1.13
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	130.78	27.96	4.51	0.45	0.45	1.35	0.45
CD4+ T Cells, donor1	11225-116C1	487.03	61.41	25.71	9.28	5.36	1.79	0.00
CD4+ T Cells, donor2	11306-117C1	369.26	47.15	14.70	15.92	7.96	3.67	3.67
CD4+ T Cells, donor3	11382-118B5	267.78	43.92	10.37	12.20	3.66	3.05	1.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	139.10	11.49	7.15	0.51	1.28	0.00	1.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	155.42	10.33	6.29	1.57	2.02	0.90	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	170.18	8.62	6.32	0.00	0.86	0.00	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	213.82	33.19	9.01	0.47	1.90	0.47	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	224.04	28.80	15.45	0.70	2.11	0.70	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	283.48	19.78	19.78	3.30	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	114.60	13.44	4.77	0.87	1.16	0.87	1.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	102.69	7.29	3.90	4.41	3.39	1.53	0.85
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	111.23	7.25	4.84	3.71	1.93	1.45	1.29
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	146.15	22.41	4.48	0.90	0.90	0.90	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	184.13	16.77	8.73	0.70	2.10	0.35	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	320.75	28.16	8.36	2.64	1.76	0.88	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	142.09	23.61	3.37	2.53	0.84	0.84	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	100.98	9.35	2.70	5.40	3.95	1.66	0.83
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	101.91	11.03	4.34	2.00	1.67	1.00	1.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	275.74	42.15	9.25	4.08	2.45	1.36	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	398.21	51.45	10.18	1.61	1.07	1.61	3.22
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	303.06	32.28	3.59	0.00	3.59	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	127.95	21.70	5.01	1.11	0.56	1.11	0.93
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	116.97	12.35	4.55	0.43	0.87	0.22	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	135.55	10.72	5.25	1.47	0.42	0.42	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	178.48	24.77	5.56	1.01	1.01	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	186.30	23.83	6.93	0.87	1.30	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	352.57	35.30	10.90	4.79	3.05	0.44	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	223.68	19.79	5.44	0.49	0.99	1.48	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	199.41	23.08	4.62	0.92	0.00	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	150.75	18.15	1.40	0.00	0.00	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	284.13	31.57	4.71	0.28	0.83	0.28	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	321.95	23.56	5.64	0.98	0.74	1.23	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	275.66	9.24	1.54	1.54	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	250.68	23.99	5.01	1.79	0.72	0.36	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	206.36	19.39	5.54	1.38	0.00	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	351.30	59.26	15.06	6.55	1.96	1.96	0.98
CD8+ T Cells, donor2	11307-117C2	334.13	52.56	10.51	12.39	2.25	0.75	1.88
CD8+ T Cells, donor3	11383-118B6	380.00	63.88	17.93	21.21	4.54	2.02	0.76
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	88.77	11.24	3.21	1.84	2.98	2.06	0.92
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	91.54	12.46	4.31	2.88	2.88	1.20	1.44
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	74.42	16.69	3.83	1.92	3.28	1.09	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	94.87	23.72	4.80	0.90	2.10	0.60	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	79.91	17.76	1.44	0.72	1.92	0.48	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	83.68	14.10	3.41	1.14	1.14	0.45	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	81.70	18.90	3.26	1.09	1.52	0.65	1.30
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	92.65	16.85	2.37	1.05	1.32	1.05	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	86.54	15.48	4.22	1.41	2.58	1.17	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	98.41	15.70	4.23	2.42	3.62	0.91	2.11
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	73.79	14.53	2.32	2.03	1.16	0.58	0.87
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	75.40	14.92	3.20	0.53	1.33	0.27	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	66.54	17.51	0.88	1.75	0.44	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	69.23	20.04	1.82	0.46	1.37	0.46	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	111.13	24.61	2.24	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	60.51	11.16	2.52	0.72	0.72	0.72	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	68.77	14.39	1.73	0.29	0.86	1.15	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	60.81	11.55	2.36	0.47	0.94	0.24	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	113.45	18.70	4.75	1.90	1.90	1.58	1.27
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	98.11	18.45	2.15	2.15	1.85	0.92	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	81.75	15.07	1.92	1.28	2.56	0.64	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	87.20	17.59	3.82	0.76	2.68	0.38	1.53
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	75.27	14.98	3.15	1.97	1.97	0.39	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	75.64	8.32	3.03	0.00	3.03	1.51	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	144.53	23.29	3.21	0.80	0.80	0.80	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	144.08	28.68	2.80	1.40	0.70	0.70	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	173.30	29.05	4.01	2.00	5.01	1.00	1.00
Cardiac Myocyte, donor1	11525-119I4	38.38	7.31	0.00	0.00	0.00	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	26.19	1.98	0.49	0.49	0.49	0.99	0.49
Cardiac Myocyte, donor3	11686-122I3	17.78	4.42	0.21	0.21	0.53	0.21	0.21
Chondrocyte - de diff, donor1	11261-116G1	58.59	3.81	2.43	1.04	1.73	1.73	0.00
Chondrocyte - de diff, donor2	11338-117F6	22.03	3.91	1.07	0.36	0.36	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	20.03	4.44	1.14	2.62	2.84	2.39	1.02
Chondrocyte - re diff, donor2	11339-117F7	80.57	15.22	2.69	0.00	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	35.59	6.07	0.81	0.40	0.40	0.40	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	82.51	21.92	5.97	2.30	2.41	0.80	0.57
Ciliary Epithelial Cells, donor2	11323-117D9	52.80	15.82	2.78	2.14	1.92	1.28	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	58.67	14.78	3.72	3.36	2.48	1.24	1.42
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	76.85	14.31	6.51	0.46	1.47	1.10	0.55
Corneal Epithelial Cells, donor1	11526-119I5	10.76	0.88	0.88	0.22	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	20.48	6.83	1.14	1.14	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	16.62	4.86	1.28	0.00	0.00	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	71.82	6.11	4.95	0.66	0.50	0.66	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	78.22	5.05	2.52	1.26	0.63	0.32	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	27.61	13.80	3.45	0.00	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	48.70	7.88	3.35	1.51	1.19	0.43	1.08
Dendritic Cells - plasmacytoid, donor1	11228-116C4	224.80	19.47	8.88	1.37	0.34	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	212.18	17.63	15.02	0.00	0.65	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	292.30	22.75	12.10	0.00	0.48	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	15.84	2.84	0.00	0.17	0.17	0.00	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	17.02	3.52	1.17	0.59	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	24.89	6.79	0.57	0.28	0.00	0.28	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	22.02	3.93	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	20.07	6.11	0.58	0.29	0.29	0.00	0.58
Endothelial Cells - Artery, donor2	11341-117F9	35.06	8.47	1.65	1.18	2.82	0.71	0.47
Endothelial Cells - Artery, donor3	11413-118E9	18.23	5.08	1.05	0.18	0.18	0.18	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	56.08	14.19	1.33	0.44	0.44	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	62.98	11.56	1.83	1.52	0.00	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	69.07	15.50	2.26	0.56	1.69	1.13	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	18.42	6.24	0.59	0.59	0.30	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	21.35	8.33	0.52	0.52	1.04	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	11.34	2.41	0.43	0.57	0.28	0.14	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	64.02	29.21	1.60	0.00	2.80	0.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	15.72	8.91	0.00	0.00	0.00	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	95.42	30.19	2.98	0.87	1.86	0.62	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	49.10	13.69	2.39	0.22	0.65	0.43	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	68.27	14.53	1.59	0.49	0.85	0.37	0.12
Endothelial Cells - Vein, donor1	11267-116G7	13.65	5.69	1.14	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	16.76	4.19	1.40	0.00	0.70	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	23.39	6.44	1.88	0.47	0.79	0.47	0.16
Eosinophils, donor1	12244-129H3	121.98	15.25	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	599.05	51.16	23.10	8.25	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	431.59	39.24	14.27	7.13	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	9.04	1.95	0.73	0.24	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	4.16	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	36.54	3.69	2.05	1.23	1.23	0.41	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	8.87	2.30	0.88	0.22	0.44	0.44	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	14.19	2.49	0.87	0.22	0.33	0.22	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	53.36	12.13	1.94	0.73	2.67	0.49	0.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	141.11	36.16	10.64	2.32	1.50	1.36	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	27.95	4.43	0.84	1.16	0.74	1.05	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	127.27	20.82	4.22	2.11	2.63	0.79	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	35.55	7.31	3.65	3.32	1.33	0.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	25.86	8.17	0.45	0.00	0.00	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	26.53	4.55	0.00	0.76	0.00	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	17.51	3.47	0.32	0.63	1.10	0.32	0.32
Fibroblast - Cardiac, donor4	11452-119A3	69.71	10.00	2.12	0.91	0.30	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	47.08	9.39	2.41	0.89	0.38	0.13	0.25
Fibroblast - Cardiac, donor6	11460-119B2	44.42	8.19	2.27	0.45	0.30	0.15	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	39.93	4.02	1.74	0.00	0.27	0.27	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	34.95	8.63	1.29	0.00	0.00	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	41.01	13.18	0.00	4.39	1.46	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	47.28	4.61	1.38	0.69	0.00	0.23	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	37.48	5.09	0.85	0.85	0.51	0.85	0.17
Fibroblast - Dermal, donor1	11269-116G9	32.87	3.52	2.11	0.47	2.11	0.47	0.23
Fibroblast - Dermal, donor2	11346-117G5	30.66	4.25	1.42	0.00	0.47	0.47	0.47
Fibroblast - Dermal, donor3	11418-118F5	30.10	6.89	2.78	4.59	6.77	2.30	1.93
Fibroblast - Dermal, donor4	11450-119A1	53.36	10.74	2.94	0.11	0.68	0.23	0.00
Fibroblast - Dermal, donor5	11454-119A5	66.64	10.64	4.19	0.35	0.70	0.52	0.35
Fibroblast - Dermal, donor6	11458-119A9	79.26	16.57	4.39	0.49	0.32	0.32	0.16
Fibroblast - Gingival, donor1	11237-116D4	82.88	10.83	2.71	0.00	0.42	0.83	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	76.50	10.74	3.14	0.26	1.31	1.05	0.52
Fibroblast - Gingival, donor2	11318-117D4	56.27	10.41	3.03	3.69	3.43	2.11	1.19
Fibroblast - Gingival, donor3	11394-118C8	62.17	7.73	3.19	0.68	0.29	0.29	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	59.22	9.35	2.08	0.00	4.16	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	28.19	4.76	1.59	2.11	1.94	1.06	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	71.87	17.30	4.05	1.87	2.65	1.87	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	60.18	10.01	3.52	0.41	1.76	1.76	0.81
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	53.28	8.47	6.70	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	59.67	11.41	2.63	1.17	2.05	1.46	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	65.59	9.95	3.14	1.50	2.32	1.23	0.68
Fibroblast - Gingival, donor8 (control)	11926-125H9	77.44	18.98	4.17	0.77	2.41	1.10	0.99
Fibroblast - Gingival, donor9 (control)	11927-125I1	75.72	9.54	2.79	0.59	0.73	0.59	0.29
Fibroblast - Lung, donor1	11270-116H1	14.95	2.72	1.36	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	70.13	8.95	2.98	1.49	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	32.50	6.12	2.74	1.06	1.06	1.06	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	24.99	1.67	0.00	0.00	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	8.39	2.80	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	7.56	1.68	0.00	0.00	0.28	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	47.09	6.90	1.62	0.81	0.00	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	23.97	7.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	73.13	14.16	3.30	0.78	2.72	2.72	0.97
Fibroblast - Periodontal Ligament, donor2	11319-117D5	91.16	14.56	4.10	2.12	1.21	1.21	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	133.41	18.05	5.81	0.31	0.31	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	43.51	7.25	4.20	0.76	0.76	0.38	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	35.10	5.13	2.97	0.54	1.08	0.27	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	27.72	3.71	1.28	0.23	0.35	0.23	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	32.83	7.96	1.11	0.66	1.33	0.44	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	30.48	3.45	1.02	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	25.39	5.35	0.00	0.67	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	20.95	3.16	0.40	0.00	2.77	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	167.49	32.74	9.92	1.98	4.37	4.17	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	57.90	7.64	2.66	1.78	1.78	0.89	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	67.21	11.83	2.76	0.59	1.58	1.38	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	95.97	24.07	7.82	2.41	1.50	1.20	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	66.39	15.55	3.67	0.54	1.30	0.32	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	132.86	15.94	5.57	1.77	1.52	1.27	1.27
Fibroblast - skin normal, donor1	11553-120C5	45.29	5.58	2.30	0.66	0.82	0.66	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	190.48	34.69	11.83	7.82	2.21	1.60	1.00
Fibroblast - skin normal, donor2	11561-120D4	64.50	12.16	2.11	0.10	1.00	0.40	0.30
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	167.74	25.69	8.46	4.84	6.35	2.12	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	58.41	9.61	2.32	0.91	0.58	0.17	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	73.00	12.48	1.88	0.85	0.85	0.17	0.68
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	126.77	15.44	7.88	2.30	3.61	1.97	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	56.67	10.76	3.20	0.53	0.75	0.75	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	48.24	9.45	1.86	1.01	2.19	0.84	0.67
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	14.58	1.73	0.47	0.47	0.31	0.16	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	509.68	110.80	0.00	0.00	66.48	22.16	66.48
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	142.93	20.05	5.23	0.87	0.00	0.87	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	33.11	8.15	1.39	0.35	0.35	0.17	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	52.57	11.71	4.68	0.00	0.52	0.52	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	45.74	14.31	3.83	0.51	0.26	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	52.06	19.14	0.77	0.77	0.77	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	63.81	26.16	3.83	0.64	1.91	1.28	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	126.66	50.21	4.28	10.55	6.85	2.28	3.42
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	209.02	33.64	8.55	8.00	8.55	5.24	2.76
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	150.24	30.82	4.34	3.65	3.88	3.20	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	107.98	30.71	4.56	6.14	3.57	2.58	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	161.24	33.31	7.40	5.29	6.34	1.85	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	175.79	33.27	7.83	3.26	2.94	3.26	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	115.86	28.74	4.86	10.61	6.63	3.98	2.21
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	85.36	31.80	3.96	4.24	3.82	1.70	1.27
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	68.10	22.54	2.96	2.96	2.96	1.60	1.35
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	66.08	25.79	4.03	3.22	4.84	2.15	1.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	51.17	17.72	1.86	1.49	2.35	1.24	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	56.20	18.41	3.05	1.80	2.91	1.66	0.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	48.59	23.38	2.85	2.03	3.46	2.24	1.42
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	44.72	15.97	3.65	0.68	3.19	0.91	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	60.29	13.95	2.62	2.62	2.62	2.12	1.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	64.92	15.52	2.40	3.06	1.31	1.31	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	44.91	14.48	0.59	1.18	1.77	1.18	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	62.95	18.60	2.23	0.95	3.02	0.79	0.79
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	50.05	15.19	1.56	0.89	1.56	0.67	1.56
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	43.75	15.32	1.81	2.02	3.63	1.61	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	53.61	19.51	2.04	3.39	3.39	2.04	1.53
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	80.78	28.73	2.66	1.42	0.89	0.98	0.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	78.77	23.83	2.29	0.42	0.52	0.52	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	80.95	25.96	2.39	0.34	0.17	0.51	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	59.31	15.71	1.33	1.22	1.55	0.55	0.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	74.63	24.04	2.33	0.83	2.08	0.75	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	71.67	23.07	2.65	1.02	0.61	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	48.28	12.58	1.86	0.62	1.65	1.03	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	55.11	15.22	1.38	1.96	2.65	1.15	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	49.70	19.85	2.00	2.50	2.00	0.67	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	34.17	9.04	0.88	3.09	1.98	1.32	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	60.02	12.91	1.35	2.09	2.71	1.23	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	50.74	17.34	2.76	2.92	3.57	1.30	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	44.58	10.26	1.60	3.53	1.60	1.28	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	38.38	10.42	1.14	1.23	1.14	1.04	0.76
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	35.27	11.23	1.11	2.37	1.74	1.27	0.95
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	40.75	12.77	1.22	1.22	2.43	2.43	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	43.07	10.45	1.99	1.25	2.09	1.36	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	36.67	12.08	1.10	1.76	1.10	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	35.91	10.94	0.84	2.81	2.52	1.12	1.12
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	50.74	13.52	2.31	1.20	0.28	0.28	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	34.76	10.43	1.07	0.80	3.21	0.27	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	40.09	13.31	1.22	1.53	2.14	1.07	1.22
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	35.49	10.88	1.55	1.17	1.68	0.39	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	29.82	11.11	1.63	0.81	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	40.93	12.54	1.11	1.84	2.03	0.92	0.92
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	39.91	10.31	1.32	1.97	2.41	1.32	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	61.49	31.74	1.98	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	37.46	7.91	1.85	1.98	1.45	1.06	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	32.08	6.46	0.61	2.62	1.21	0.40	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	103.95	20.59	2.54	0.76	0.00	0.25	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	123.22	57.13	6.37	2.39	5.37	1.79	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	108.62	34.67	4.01	5.08	5.24	3.24	2.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	131.34	50.94	5.52	3.27	4.30	3.07	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	37.86	16.59	1.56	0.00	0.31	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	37.86	15.54	2.26	0.57	0.28	1.13	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	137.90	51.65	5.53	4.15	5.07	4.15	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	84.14	27.22	2.47	4.95	7.42	0.00	9.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	80.46	39.84	1.93	4.64	6.58	4.64	2.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	70.60	36.90	0.00	0.00	8.02	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	93.90	38.25	3.48	5.22	6.96	3.48	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	65.42	34.83	2.28	2.28	4.88	1.30	1.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	80.71	35.41	4.53	1.24	4.53	3.71	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	96.64	33.32	6.66	26.66	19.99	16.66	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	77.46	35.52	1.96	2.80	4.75	2.24	1.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	80.73	23.21	2.29	1.63	6.54	1.31	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	98.14	29.36	5.03	7.55	5.03	10.07	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	90.65	29.90	0.64	2.54	4.77	3.50	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	62.16	21.40	1.02	2.04	5.77	0.68	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	77.26	18.79	4.18	6.26	4.18	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	76.17	26.34	2.86	1.72	1.15	1.72	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	39.66	14.80	0.89	0.89	4.44	1.18	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	60.99	32.19	3.39	0.00	10.16	1.69	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	76.63	32.31	0.83	0.83	9.53	0.83	2.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	72.49	20.71	0.92	1.61	2.53	1.15	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	89.56	31.61	5.27	10.54	10.54	5.27	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	71.50	17.30	0.38	3.84	2.31	3.08	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	58.02	20.54	0.98	1.96	3.91	1.30	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	53.51	10.70	1.34	0.00	1.34	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	69.35	14.64	1.16	3.08	3.85	1.16	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	85.24	40.40	2.05	3.77	6.16	4.11	2.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	124.24	19.88	9.94	9.94	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	73.14	14.16	2.83	1.42	2.83	1.42	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	57.33	13.88	2.41	1.81	4.83	1.81	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	86.47	21.87	3.05	1.02	1.02	0.51	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	86.55	23.53	3.59	5.58	5.18	1.60	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	98.67	19.24	2.47	2.47	4.44	3.45	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	129.85	36.59	8.26	2.36	5.90	1.18	4.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	71.18	11.67	0.00	1.17	5.25	0.58	2.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	90.85	12.29	0.44	0.88	3.95	1.76	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	69.51	27.13	2.54	5.09	6.78	2.54	5.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	56.71	14.33	0.60	1.79	2.98	0.00	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	51.92	15.04	1.46	2.43	3.88	1.46	3.40
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	21.68	3.42	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	25.36	5.41	1.25	3.33	1.66	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	7.87	6.75	1.12	0.00	0.00	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	34.25	5.71	2.54	0.63	2.22	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	18.80	1.25	1.25	1.25	0.42	0.42	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	35.16	15.90	1.74	1.74	3.37	2.20	1.74
Hep-2 cells mock treated, biol_rep2	11899-125E9	48.61	21.44	4.05	1.52	3.38	2.19	1.69
Hep-2 cells mock treated, biol_rep3	11900-125F1	44.59	23.21	3.19	1.82	5.46	2.96	1.82
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	40.23	16.72	2.62	2.08	4.15	2.51	1.75
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	45.13	21.28	3.87	1.29	3.87	1.72	1.07
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	51.24	19.38	1.72	2.37	4.09	3.01	1.08
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	29.64	11.83	2.62	1.74	2.86	1.37	0.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	29.68	15.10	1.37	0.69	2.74	1.54	1.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	23.39	14.74	1.28	1.60	5.13	1.28	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	21.83	3.36	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	16.88	3.90	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	29.08	15.86	2.64	5.29	0.00	0.00	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	17.28	2.12	1.06	0.35	0.00	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	15.26	1.45	0.73	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	23.95	7.34	1.22	0.35	1.05	0.17	0.17
Hepatocyte, donor1	11523-119I2	77.48	18.16	2.42	3.63	1.21	1.21	0.00
Hepatocyte, donor2	11603-120I1	65.72	15.08	0.00	1.08	2.15	0.00	0.00
Hepatocyte, donor3	11684-122I1	83.44	12.88	2.45	6.14	3.07	1.23	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	105.74	49.60	5.22	1.31	2.61	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	93.16	27.62	2.27	1.22	2.10	1.22	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	37.59	8.10	2.06	1.37	1.65	0.55	1.10
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	73.23	22.29	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	6.68	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	27.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	53.99	19.38	4.15	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	35.04	5.01	2.50	0.00	0.00	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	74.32	30.75	2.56	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	4.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	71.47	27.61	3.25	0.00	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	88.37	21.67	5.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	47.20	10.89	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	90.00	30.44	2.65	0.00	0.00	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	65.41	23.28	4.43	1.11	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	47.14	26.19	5.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	86.92	17.01	1.26	0.00	0.00	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	60.32	20.11	4.64	0.00	0.00	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	98.84	27.78	7.11	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	107.87	35.42	1.61	0.00	3.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	131.43	35.84	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	106.75	14.67	5.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	63.81	18.47	2.52	0.00	0.42	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	114.98	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	116.53	35.36	4.82	0.80	0.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	40.62	16.62	1.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	105.57	30.16	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	47.20	15.11	1.42	0.00	1.89	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	36.28	23.58	2.72	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	206.39	73.71	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	94.70	25.83	5.38	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	59.71	27.95	2.54	0.00	0.00	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	115.01	49.29	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	91.83	29.33	3.19	0.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	61.97	16.40	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	79.02	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	82.12	23.56	2.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	92.91	26.55	3.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	83.39	20.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	37.04	10.80	1.54	0.31	0.00	0.31	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	73.75	29.85	1.76	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	66.01	25.15	6.29	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	87.62	14.60	2.78	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	28.77	13.28	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	29.18	3.24	3.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	49.70	5.23	1.74	0.00	0.00	0.00	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	38.25	11.25	4.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	52.27	3.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	36.27	9.60	2.13	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	45.72	20.78	2.77	0.00	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	62.69	25.65	2.85	0.00	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	39.58	7.36	0.92	0.00	1.84	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	18.15	12.10	3.03	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	31.04	0.00	6.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	35.95	4.23	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	39.74	11.02	2.69	0.24	0.98	0.24	0.08
Keratinocyte - epidermal, donor2	11349-117G8	6.44	1.17	0.59	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	40.80	9.56	3.31	2.75	3.79	2.18	1.23
Keratinocyte - oral, donor1	11251-116E9	66.29	8.74	2.16	1.48	2.16	0.79	0.34
Keratocytes, donor1	11527-119I6	46.42	6.53	1.38	0.00	0.69	0.34	0.00
Keratocytes, donor2	11607-120I5	11.72	2.34	0.00	0.00	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	31.81	1.78	1.78	1.78	1.19	0.40	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	72.53	15.39	4.40	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	37.76	7.55	1.08	3.24	1.08	2.16	2.16
Lens Epithelial Cells, donor2	11609-120I7	47.86	7.84	1.85	1.27	2.08	0.58	0.58
Lens Epithelial Cells, donor3	11690-122I7	29.47	6.66	1.31	0.20	0.91	0.20	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	16.13	4.86	0.47	0.24	0.83	0.24	0.36
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	10.05	5.02	0.00	0.56	0.84	0.56	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	25.34	9.92	1.57	2.83	3.78	1.89	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	8.60	5.91	0.54	0.00	0.00	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	11.35	1.26	0.00	0.95	0.95	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	8.95	2.16	0.43	0.97	0.97	0.32	0.75
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	20.93	5.75	1.23	2.05	1.64	0.00	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	9.35	3.29	0.00	0.00	0.25	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	10.98	3.38	0.56	1.55	1.83	0.56	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	21.36	3.96	1.19	0.40	1.19	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	16.29	5.62	0.58	0.39	1.94	0.78	0.97
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	5.37	1.30	0.19	0.00	0.00	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	18.47	5.23	0.70	1.39	1.39	1.39	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	15.98	1.67	0.95	1.19	1.67	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	9.20	2.75	0.55	0.41	1.37	0.14	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	17.55	6.47	0.31	1.85	2.77	0.62	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	7.48	1.56	0.62	0.00	0.94	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	13.72	3.48	1.28	0.37	1.65	1.10	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	17.77	5.27	0.33	0.33	0.99	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	10.25	2.05	0.29	0.59	0.29	0.59	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	6.47	2.74	0.25	0.25	0.00	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	22.31	5.82	0.48	1.45	1.94	1.45	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	20.74	6.73	1.35	0.27	2.42	0.27	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	11.66	3.48	0.91	0.61	1.97	0.45	0.76
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	12.96	5.70	2.07	1.04	1.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	28.27	7.75	2.93	0.63	1.88	0.84	0.84
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	11.43	3.01	0.90	0.45	1.20	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	16.51	5.50	0.69	0.69	0.00	1.38	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	15.62	5.27	1.32	0.00	1.69	0.00	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	9.44	1.48	0.32	0.53	1.06	0.64	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	18.90	3.88	2.42	0.48	1.45	0.48	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	11.25	1.98	0.99	0.66	0.33	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	8.55	3.10	0.12	0.62	0.99	0.99	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	32.21	8.14	1.48	2.59	3.70	1.11	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	16.06	3.71	0.99	0.49	1.24	0.49	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	5.77	2.34	0.41	0.27	1.10	0.27	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	23.16	7.08	0.96	0.32	3.22	0.96	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	21.61	10.65	0.91	0.91	2.74	1.22	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	16.94	4.76	0.84	0.98	2.38	1.82	0.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	24.89	6.04	0.00	1.07	2.84	1.07	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	10.67	3.88	0.00	0.00	1.45	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	6.69	2.02	0.16	0.16	0.78	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	13.97	4.30	0.72	0.36	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	12.09	5.55	1.31	0.00	0.00	0.65	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	6.12	2.12	0.24	0.47	0.47	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	15.10	6.81	0.74	0.99	0.12	0.25	0.50
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	15.11	2.82	1.28	0.26	0.26	1.02	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	9.85	2.39	0.60	0.00	0.90	0.60	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	29.46	2.27	2.27	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	26.85	5.37	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	29.69	4.45	2.23	0.00	1.48	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	37.24	8.46	1.27	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	27.43	4.22	0.70	0.70	0.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	28.95	11.21	0.93	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	24.73	8.24	2.58	0.00	1.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	19.03	8.33	1.19	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	21.49	3.62	2.49	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	40.13	7.27	1.16	0.58	1.16	0.87	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	38.72	8.55	1.35	0.00	1.80	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	30.08	7.99	1.08	0.00	0.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	41.60	9.24	1.03	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	35.29	9.53	2.12	1.76	0.35	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	33.98	7.33	0.67	0.00	0.67	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	47.37	12.73	1.53	0.00	0.00	1.02	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	42.42	10.67	1.87	1.60	1.60	0.80	1.07
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	49.13	10.77	2.46	0.38	1.51	0.57	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	49.70	14.73	1.84	1.23	0.61	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	39.14	13.86	2.45	0.00	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	54.35	12.91	2.92	2.50	1.87	1.46	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	47.92	13.73	1.40	0.00	1.68	0.28	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	41.21	8.24	1.03	0.00	2.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	44.13	12.19	1.16	2.90	2.32	2.03	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	44.84	13.75	1.20	0.30	0.90	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	39.28	11.07	3.32	2.21	0.00	0.55	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	38.18	10.96	1.77	0.71	0.35	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	52.00	9.96	2.21	0.74	1.11	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	35.69	5.76	5.76	0.00	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	41.83	16.12	1.54	0.77	0.38	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	46.42	6.79	0.57	0.00	2.26	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	44.31	10.67	0.82	0.00	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	41.57	7.68	0.90	0.45	0.90	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	40.22	11.49	0.72	0.00	0.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	38.09	6.72	1.49	0.00	0.00	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	33.44	7.43	2.23	0.00	2.23	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	50.83	9.48	0.86	0.00	0.00	1.72	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	41.10	13.70	2.57	2.57	1.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	45.65	9.66	0.67	0.33	1.00	1.00	1.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	44.04	7.84	1.81	0.00	0.60	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	33.42	4.98	1.42	0.00	0.00	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	36.09	7.22	1.72	0.34	0.34	1.03	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	41.87	7.51	0.54	0.54	0.00	0.54	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	26.26	14.14	2.69	0.00	0.00	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	42.97	9.26	0.74	1.48	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	30.24	12.79	2.33	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	26.44	6.35	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	35.61	12.00	2.00	0.40	1.20	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	53.06	14.54	2.91	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	44.46	9.20	0.77	0.00	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	42.42	7.89	1.97	0.00	0.00	0.49	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	46.11	7.53	0.94	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	29.67	10.06	1.01	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	38.30	9.01	1.35	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	65.40	18.93	1.72	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	50.32	12.47	0.45	0.00	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	43.79	16.03	3.91	0.00	0.39	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	54.76	17.81	1.32	0.00	0.00	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	47.22	14.01	1.56	0.52	1.56	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	50.76	10.50	2.19	0.00	0.44	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	56.47	13.98	1.68	0.56	0.56	0.56	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	45.49	9.72	0.88	0.44	0.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	45.90	11.57	3.47	0.00	0.39	1.16	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	54.69	13.17	1.01	0.51	0.00	0.51	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	46.62	17.30	2.88	0.00	0.96	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	46.51	11.13	2.39	0.00	1.59	1.19	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	48.61	9.11	2.43	0.00	0.61	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	47.73	12.45	0.69	0.00	0.69	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	44.84	13.30	1.90	0.38	1.52	0.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	54.22	17.56	2.07	0.00	1.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	38.09	12.70	1.21	0.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	49.44	11.73	1.27	0.63	0.63	0.63	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	52.24	13.33	2.13	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	45.97	9.19	2.87	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	52.97	14.40	1.54	0.51	2.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	50.22	14.85	2.83	0.00	1.41	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	45.40	11.92	1.13	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	52.84	9.15	1.25	0.00	0.42	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	53.25	14.09	2.35	0.00	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	44.68	10.44	2.51	0.00	0.84	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	46.46	13.01	2.79	0.00	0.00	0.46	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	48.17	12.04	0.67	0.00	0.00	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	43.31	7.48	0.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	40.81	10.91	0.40	0.00	2.02	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	52.31	5.51	1.84	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	47.12	5.33	1.78	0.00	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	49.58	14.25	1.71	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	52.92	8.44	3.07	0.00	1.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	54.72	14.23	2.74	0.00	0.55	0.55	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	48.55	8.46	1.34	0.89	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	34.83	5.72	1.82	0.00	0.52	0.26	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	51.72	11.27	1.99	0.00	0.66	0.66	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	64.44	14.55	2.08	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	56.52	7.52	1.37	0.68	0.00	0.00	0.23
Macrophage - monocyte derived, donor2	11313-117C8	47.71	6.61	2.20	0.73	0.92	0.18	0.00
Macrophage - monocyte derived, donor3	11389-118C3	38.80	7.60	1.97	1.44	1.18	0.39	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	24.96	4.25	0.00	0.00	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	66.07	18.86	3.01	0.95	1.43	0.95	0.32
Mallassez-derived cells, donor3	11930-125I4	54.34	16.26	1.67	0.42	1.11	0.83	0.69
Mammary Epithelial Cell, donor1	11273-116H4	61.28	15.15	2.99	3.69	6.68	3.29	2.49
Mammary Epithelial Cell, donor2	11350-117G9	49.22	13.03	2.90	2.32	2.32	2.03	1.16
Mammary Epithelial Cell, donor3	11422-118F9	12.72	2.49	1.75	0.25	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	983.01	197.96	29.15	1.36	0.68	0.00	0.00
Mast cell, donor1	11563-120D6	104.46	13.95	3.35	2.81	0.43	1.62	0.22
Mast cell, donor2	11565-120D8	185.14	23.77	15.45	3.57	0.89	0.89	0.00
Mast cell, donor3	11566-120D9	200.14	24.31	16.88	1.80	0.68	1.13	0.23
Mast cell, donor4	11567-120E1	186.33	17.55	14.01	1.60	1.06	0.53	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	118.77	18.74	5.88	2.22	1.77	1.00	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	145.92	15.18	3.50	0.00	1.17	1.17	0.58
Mast cell, expanded, donor5	11939-126A4	97.63	12.05	4.70	0.23	0.92	0.57	0.92
Mast cell, expanded, donor8	11941-126A6	101.26	9.21	3.35	0.67	0.67	1.34	0.00
Melanocyte - dark, donor1	11502-119F8	24.18	9.65	0.80	0.10	0.99	0.10	0.40
Melanocyte - dark, donor2	11582-120F7	28.38	5.19	0.69	1.38	2.08	0.35	0.35
Melanocyte - dark, donor3	11663-122F7	43.17	16.52	1.52	1.01	2.46	1.01	0.72
Melanocyte - light, donor1	11274-116H5	11.52	2.35	0.24	0.71	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	8.87	3.41	0.68	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	8.67	5.20	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	39.36	13.33	1.56	1.98	2.08	0.62	0.83
Melanocyte, donor2 (MC+2)	12739-135I3	32.27	11.30	0.27	1.88	2.69	0.81	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	39.64	12.05	1.61	0.80	0.54	1.34	0.27
Meningeal Cells, donor1	11493-119E8	48.51	8.93	2.36	0.00	0.50	0.25	0.00
Meningeal Cells, donor2	11573-120E7	33.01	3.96	0.88	0.00	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	72.05	18.09	3.02	0.57	2.36	0.98	0.57
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	42.20	7.13	1.14	0.29	1.43	0.57	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	55.25	9.66	3.32	0.30	0.40	0.00	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	14.46	1.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	10.47	3.92	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	38.75	5.74	2.87	0.00	2.87	1.44	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	44.68	6.35	2.96	0.64	2.33	0.85	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	29.15	6.03	1.01	0.00	2.01	0.00	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	22.63	5.93	1.10	0.44	0.44	0.44	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	23.38	3.65	1.46	0.73	0.73	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	19.23	3.89	1.43	0.61	0.20	0.00	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	36.15	4.16	1.52	0.55	0.69	0.28	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	11.52	2.23	1.12	0.37	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	35.00	6.45	0.92	1.58	1.71	0.79	0.79
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	12.46	2.37	0.59	0.30	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	4.67	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	21.13	4.48	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	44.66	9.57	1.42	0.35	0.71	0.35	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	25.96	6.25	0.94	0.00	0.63	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	21.77	5.81	4.35	0.73	0.73	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	38.98	6.89	2.65	0.80	0.80	1.06	0.27
Mesothelial Cells, donor2	12156-128G5	21.02	7.01	2.00	0.00	0.00	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	25.51	7.66	1.23	3.76	2.24	1.66	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	27.01	6.75	4.05	0.00	0.00	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	41.62	5.91	2.22	1.48	0.49	0.49	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	48.88	9.13	1.77	1.18	0.88	0.29	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	20.74	6.91	3.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	41.84	3.41	1.86	0.00	0.00	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	29.87	3.73	1.04	1.87	1.04	1.04	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	13.90	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	34.54	5.76	1.50	0.25	0.00	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	46.55	6.05	2.79	0.93	1.40	0.47	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	23.57	3.25	1.83	0.41	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	42.37	6.34	0.00	1.98	0.40	0.40	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	8.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	23.89	0.88	1.77	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	30.77	5.70	1.90	1.14	1.52	0.76	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	28.95	3.95	0.00	0.00	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	20.37	4.67	0.21	0.85	0.64	0.21	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	34.07	2.76	0.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	17.88	1.79	0.30	0.89	0.60	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	28.50	5.03	3.35	1.68	0.00	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	22.83	3.76	1.51	0.50	1.00	0.00	0.75
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	30.18	3.33	2.14	1.43	1.43	0.71	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	23.22	8.29	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	22.33	5.07	0.92	0.92	0.46	0.69	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	27.13	6.52	0.63	0.63	0.84	0.42	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	28.13	5.71	1.43	0.41	0.82	0.82	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	28.96	6.01	1.07	0.86	0.21	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	31.57	6.00	0.44	0.89	0.67	0.44	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	25.41	5.91	1.10	0.22	0.66	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	27.88	4.06	1.01	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	29.83	3.31	0.00	0.00	0.00	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	36.42	6.52	2.45	0.00	0.27	0.00	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	44.11	7.06	2.06	0.00	0.00	1.18	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	30.53	2.18	2.18	0.00	0.00	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	20.66	0.96	0.96	0.00	0.00	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	35.22	6.00	2.80	0.00	0.80	0.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	46.62	12.34	1.37	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	21.52	5.01	1.00	1.00	0.50	1.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	26.50	6.12	2.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	40.29	5.26	1.31	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	36.42	4.41	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	30.74	12.17	0.64	0.00	1.92	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	38.92	5.95	1.49	1.49	0.74	0.50	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	34.10	3.48	3.48	0.00	0.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	26.52	4.42	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	30.09	5.13	0.68	0.68	1.03	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	44.64	5.69	1.31	0.00	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	33.02	4.62	2.13	0.36	0.71	1.07	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	33.67	7.29	1.68	0.84	0.84	1.12	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	51.54	4.57	1.66	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	36.13	3.50	0.00	0.00	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	28.05	6.64	0.90	0.60	0.60	0.90	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	51.34	5.01	2.50	0.42	0.42	0.00	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	57.75	7.22	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	44.33	3.69	2.77	1.85	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	46.10	8.54	0.57	0.00	1.71	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	38.69	5.80	2.76	1.24	0.55	0.28	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	27.99	5.70	2.59	0.52	0.52	0.52	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	44.18	10.30	1.29	0.00	0.86	0.86	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	28.58	3.81	0.64	0.64	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	30.69	4.27	1.60	1.60	0.00	1.07	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	46.99	10.78	2.39	0.60	1.20	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	33.05	4.66	1.55	0.57	0.14	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	27.39	5.41	2.55	0.96	0.00	0.64	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	57.05	6.41	2.65	0.66	1.11	0.44	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	32.23	4.55	1.14	0.38	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	40.91	5.40	1.14	1.70	1.14	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	49.90	8.36	1.72	0.74	1.23	0.25	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	37.80	5.21	5.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	45.57	5.88	1.47	0.59	1.18	0.59	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	47.00	6.34	2.02	0.00	0.29	0.58	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	55.23	8.24	2.47	0.41	1.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	47.94	4.47	2.68	0.30	0.00	0.30	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	0.00	3.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	19.60	3.56	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	25.96	5.59	0.99	2.63	1.64	1.31	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	18.94	7.36	0.00	2.10	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	32.22	4.15	1.98	0.00	0.20	0.20	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	43.77	5.59	1.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	24.78	3.00	0.75	1.88	0.38	0.38	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	19.44	3.73	1.07	0.27	0.00	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	23.98	4.41	1.13	0.23	0.23	0.23	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	14.00	1.47	0.74	0.74	2.21	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	21.62	5.50	0.37	1.10	2.20	0.73	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	29.56	4.67	0.00	4.67	7.78	4.67	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	19.24	4.28	2.14	0.00	0.00	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	8.08	1.01	0.00	0.00	2.02	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	23.61	4.64	0.42	0.00	0.00	0.84	1.26
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	47.67	17.71	1.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	10.17	1.91	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	12.15	4.86	0.81	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	21.15	6.04	0.00	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	142.75	45.68	11.42	5.71	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	88.09	68.51	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	57.03	47.52	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	75.29	25.10	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	40.93	9.69	1.72	0.43	1.94	1.51	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	34.49	6.27	1.57	1.57	1.05	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	62.74	12.68	4.00	0.00	0.67	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	43.82	10.85	4.59	0.83	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	125.30	23.96	2.66	0.19	0.00	0.57	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	81.39	15.96	3.19	0.00	1.60	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	37.40	5.44	1.36	0.00	0.00	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	69.83	18.38	5.51	1.84	1.84	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	39.34	4.60	2.51	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	55.79	6.74	4.18	0.23	0.00	0.46	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	53.50	6.76	1.35	0.27	0.54	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	56.76	6.94	0.42	0.63	1.05	0.84	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	434.25	77.94	11.13	44.54	55.67	22.27	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	40.20	6.45	1.99	0.50	0.50	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	43.85	4.60	1.89	0.54	0.27	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	35.82	4.53	2.04	0.68	0.45	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	49.97	7.35	1.80	0.49	0.49	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	39.91	8.02	1.64	0.18	1.09	0.73	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	49.33	4.77	3.71	1.06	0.53	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	54.03	4.20	1.80	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	102.72	12.14	1.31	0.00	0.33	0.33	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	37.24	5.85	1.79	0.00	0.16	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	48.15	10.05	2.29	0.53	1.23	0.88	1.06
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	42.19	4.22	2.81	0.00	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	40.91	4.14	2.30	0.00	0.00	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	40.49	7.71	2.57	0.32	0.64	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	75.53	14.14	2.07	0.69	0.34	1.72	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	128.95	17.70	2.53	5.06	0.00	2.53	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	46.78	7.13	3.56	0.45	1.11	0.45	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	36.41	6.77	1.27	0.42	0.42	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	58.86	4.98	1.42	0.71	0.00	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	37.34	7.30	1.72	0.00	0.00	0.43	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	487.50	108.33	0.00	18.06	0.00	18.06	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	68.98	8.33	3.67	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	29.76	7.21	1.80	0.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	42.06	9.13	1.59	0.00	0.79	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	47.36	13.00	2.79	0.93	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	43.13	6.43	0.76	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	46.93	7.50	1.30	0.00	0.33	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	62.32	3.05	3.05	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	37.09	6.78	1.81	0.00	0.90	1.36	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	50.27	10.58	3.53	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	46.54	4.65	2.66	0.00	1.33	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	67.46	7.44	3.47	0.00	0.99	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	44.79	6.89	3.06	0.38	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	60.79	7.86	2.12	0.30	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	49.29	9.06	2.21	1.11	0.22	0.44	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	39.98	7.45	5.42	0.68	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	122.63	20.44	0.00	30.66	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	56.09	7.93	1.22	0.61	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	40.60	5.04	0.63	0.63	0.31	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	54.17	5.45	2.12	0.30	0.00	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	48.26	5.54	2.37	0.00	0.79	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	70.29	13.60	2.27	1.13	1.13	1.13	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	91.04	15.17	0.00	15.17	5.06	0.00	10.12
Myoblast, donor1	11241-116D8	44.72	13.91	3.48	0.62	1.74	0.37	0.25
Myoblast, donor2	11322-117D8	52.74	10.74	2.30	1.53	1.34	1.15	0.58
Myoblast, donor3	11398-118D3	56.50	10.93	2.19	1.01	1.01	0.67	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	69.46	24.08	1.75	4.67	3.06	1.17	0.58
Natural Killer Cells, donor1	11230-116C6	329.35	49.20	14.15	7.69	4.00	3.38	1.23
Natural Killer Cells, donor2	11311-117C6	268.39	43.12	8.14	14.78	6.63	2.71	0.60
Natural Killer Cells, donor3	11387-118C1	263.20	44.73	16.20	14.54	4.79	2.94	1.47
Neural stem cells, donor1	11275-116H6	189.09	60.25	6.90	1.45	0.73	0.36	0.00
Neural stem cells, donor2	11352-117H2	327.36	40.44	7.70	1.93	1.93	0.00	0.00
Neurons, donor1	11494-119E9	77.38	14.79	2.28	3.41	3.41	2.28	1.14
Neurons, donor2	11574-120E8	77.94	19.81	3.52	0.88	3.08	1.10	1.32
Neurons, donor3	11655-122E8	67.42	20.55	3.29	3.29	5.76	2.47	0.00
Neutrophils, donor1	11233-116C9	197.67	24.13	6.50	6.50	0.93	1.86	0.93
Neutrophils, donor2	11314-117C9	150.74	11.60	2.90	11.60	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	304.20	34.82	7.94	0.61	0.00	1.22	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	40.37	4.51	1.19	0.83	1.19	0.71	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	20.19	2.28	1.30	0.33	0.65	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	26.27	2.81	1.60	0.20	0.20	0.80	0.20
Olfactory epithelial cells, donor1	11933-125I7	36.34	3.99	1.51	3.03	2.20	1.10	0.55
Olfactory epithelial cells, donor2	11934-125I8	42.56	8.25	2.89	2.75	4.34	1.45	1.59
Olfactory epithelial cells, donor3	11935-125I9	33.60	5.22	1.70	2.38	1.82	1.25	0.23
Olfactory epithelial cells, donor4	11936-126A1	46.65	6.04	1.95	1.46	1.36	1.46	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	42.13	7.22	0.00	0.60	1.20	2.41	0.00
Osteoblast - differentiated, donor1	11276-116H7	11.70	1.28	0.85	0.21	0.00	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	8.00	1.14	0.00	1.14	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	13.03	3.10	0.62	0.00	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	11.53	2.93	0.59	0.20	0.00	0.20	0.00
Osteoblast, donor2	11354-117H4	80.06	23.88	2.11	2.11	1.40	0.70	0.00
Osteoblast, donor3	11426-118G4	24.53	5.15	1.78	0.36	0.36	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	59.13	8.76	2.70	1.18	3.79	1.60	1.01
Pericytes, donor1	11491-119E6	11.68	1.56	0.45	0.11	0.00	0.11	0.00
Pericytes, donor2	11571-120E5	13.81	1.13	0.23	0.23	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	15.26	3.05	0.41	0.00	0.20	0.00	0.00
Perineurial Cells, donor1	11499-119F5	55.38	7.12	1.58	0.90	2.37	1.81	1.24
Perineurial Cells, donor2	11579-120F4	41.40	7.18	1.10	0.74	1.20	0.46	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	327.66	30.92	10.20	1.91	1.27	1.59	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	193.69	24.00	10.53	1.71	0.73	0.49	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	184.94	25.62	8.80	2.72	0.78	0.13	0.52
Placental Epithelial Cells, donor1	11278-116H9	20.57	4.78	0.48	0.00	0.72	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	17.74	4.44	2.22	0.00	0.00	1.11	1.11
Placental Epithelial Cells, donor3	11427-118G5	13.94	3.34	0.79	0.39	0.59	0.20	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	6.96	1.58	0.63	0.00	0.63	0.32	0.32
Preadipocyte - breast, donor1	11467-119B9	39.39	8.63	1.13	0.38	0.19	0.00	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	90.32	19.71	5.22	2.35	1.96	0.52	0.26
Preadipocyte - breast, donor2	11328-117E5	20.94	4.95	2.25	1.35	1.13	0.68	0.23
Preadipocyte - omental, donor1	11468-119C1	36.12	7.14	1.17	0.11	0.11	0.21	0.11
Preadipocyte - omental, donor2	11329-117E6	40.59	9.60	2.62	0.00	0.44	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	30.23	6.59	1.00	1.86	1.43	1.43	0.00
Preadipocyte - perirenal, donor1	11469-119C2	13.78	1.97	0.98	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	12.28	5.22	1.84	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	52.95	15.05	4.07	5.49	4.78	3.54	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	34.91	8.00	3.75	1.53	1.53	0.85	0.51
Preadipocyte - visceral, donor1	11280-116I2	76.66	13.51	3.73	1.68	2.05	1.12	0.19
Preadipocyte - visceral, donor2	11357-117H7	51.54	11.04	1.84	0.92	1.84	0.92	0.00
Preadipocyte - visceral, donor3	11429-118G7	45.45	9.82	2.51	0.94	1.99	1.25	0.63
Prostate Epithelial Cells (polarized), donor1	11253-116F2	72.41	27.76	2.26	2.56	3.92	2.26	1.21
Prostate Epithelial Cells, donor2	11331-117E8	25.19	7.99	2.30	1.35	0.54	0.27	0.14
Prostate Epithelial Cells, donor3	11404-118D9	33.07	4.72	2.20	2.94	2.69	1.78	0.37
Prostate Stromal Cells, donor1	11254-116F3	50.34	8.54	2.96	0.68	1.94	1.25	0.91
Prostate Stromal Cells, donor2	11332-117E9	47.69	8.96	1.79	3.77	4.12	2.87	0.54
Prostate Stromal Cells, donor3	11405-118E1	28.99	4.80	1.98	1.25	1.98	1.15	1.15
Renal Cortical Epithelial Cells, donor1	11516-119H4	20.80	1.82	0.36	0.00	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	44.91	9.63	1.11	0.76	1.94	1.32	0.42
Renal Epithelial Cells, donor1	11517-119H5	23.33	2.03	2.03	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	17.78	1.42	0.71	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	59.18	12.49	2.54	0.85	2.75	0.95	1.16
Renal Glomerular Endothelial Cells, donor1	11514-119H2	14.98	4.09	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	20.21	2.96	0.40	0.00	0.54	0.00	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	42.85	13.10	0.89	1.55	2.22	1.11	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	18.63	1.33	1.33	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	20.91	3.74	0.44	0.22	0.44	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	16.30	2.51	0.63	0.00	0.63	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	11.37	1.94	0.83	0.00	0.00	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	33.02	8.05	0.54	0.27	0.81	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	16.87	3.37	1.69	0.42	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	18.71	4.05	0.77	0.19	0.00	0.39	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	47.71	8.82	1.04	0.26	1.81	0.78	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	24.16	4.83	1.71	0.28	0.28	0.28	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	12.35	2.06	3.09	0.00	0.00	0.00	2.06
Retinal Pigment Epithelial Cells, donor3	11689-122I6	37.39	8.28	2.26	0.50	1.25	1.25	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	88.87	19.24	1.47	0.80	2.54	2.27	0.80
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	74.15	16.08	3.57	2.68	0.00	1.79	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	143.10	47.88	1.65	9.91	18.16	9.36	7.71
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	181.56	57.43	4.64	1.16	6.38	5.80	4.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	103.37	28.61	2.86	0.26	2.08	1.17	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	65.84	16.58	2.88	2.68	6.36	2.48	1.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	97.15	28.78	2.57	1.67	2.45	1.12	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	85.71	29.40	3.60	2.85	6.45	3.23	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	62.00	20.28	2.10	3.50	4.20	2.80	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	81.82	24.73	5.08	4.85	8.09	4.85	4.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	70.78	17.66	2.88	1.37	3.29	1.23	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	70.04	23.60	3.18	6.20	4.54	3.93	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	77.23	23.65	4.12	0.18	0.54	0.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	61.26	15.49	2.15	1.00	2.44	3.01	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	61.60	19.10	1.93	2.68	3.43	1.18	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	67.93	24.34	3.32	3.10	4.20	2.88	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	76.28	21.79	3.06	0.96	3.06	1.72	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	68.75	18.82	2.98	2.61	2.24	1.68	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	121.01	33.07	2.63	3.01	4.32	3.57	1.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	74.45	19.51	3.32	0.53	1.59	0.93	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	73.69	22.19	2.63	4.67	5.74	3.31	1.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	72.76	20.43	1.34	3.06	7.45	3.06	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	71.66	20.40	1.92	0.32	2.35	1.28	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	69.24	18.50	2.80	2.80	3.92	2.52	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	74.17	26.49	2.22	4.61	5.13	2.39	2.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	67.64	17.32	1.09	0.18	1.28	0.91	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	60.34	21.34	2.70	3.07	5.76	2.08	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	65.55	21.09	2.82	2.55	4.70	2.82	2.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	75.72	16.75	2.59	0.47	4.01	0.94	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	66.67	20.04	2.78	3.37	3.97	3.37	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	85.82	20.81	2.10	2.57	3.74	3.04	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	63.24	18.45	1.66	0.83	2.49	1.66	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	75.21	21.24	2.88	1.77	3.54	2.21	1.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	80.00	23.19	3.13	1.88	2.51	1.88	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	75.10	20.05	3.10	2.02	3.10	3.10	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	84.47	29.29	2.38	1.36	2.55	1.36	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	80.97	22.94	4.24	4.82	8.68	4.63	2.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	83.56	19.26	3.09	1.55	6.02	2.24	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	76.68	24.69	2.88	1.65	3.57	1.92	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	80.11	30.04	2.79	3.94	7.39	2.96	2.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	79.76	18.58	2.73	0.85	3.41	2.05	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	73.24	24.27	2.52	5.03	10.36	4.29	5.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	72.50	21.59	2.67	1.87	4.00	1.07	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	65.54	17.97	1.52	0.28	2.49	0.14	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	48.33	17.86	0.48	3.33	4.29	4.52	1.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	88.48	25.60	2.82	3.43	3.43	1.81	2.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	46.52	17.70	1.22	0.94	0.75	1.41	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	73.37	19.56	2.10	9.43	13.28	4.89	4.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	58.02	23.87	2.12	2.72	4.53	2.42	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	50.67	18.73	0.98	0.73	1.47	1.71	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	202.61	57.35	5.24	1.02	1.02	0.58	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	77.27	20.08	2.43	0.00	1.22	1.22	3.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	53.35	12.96	1.51	0.30	1.21	1.21	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	61.07	17.19	0.68	1.81	4.07	1.58	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	87.77	24.26	3.59	7.49	4.79	2.10	1.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	70.96	23.38	1.77	0.12	1.77	1.18	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	59.76	15.58	0.85	0.64	0.85	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	112.38	18.63	4.81	3.00	0.60	0.00	0.00
Schwann Cells, donor1	11498-119F4	22.57	2.82	0.75	0.00	0.38	0.19	0.00
Schwann Cells, donor2	11578-120F3	61.24	3.40	3.40	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	30.45	5.70	2.19	1.10	1.31	0.44	0.88
Sebocyte, donor1	11220-116B5	20.82	7.12	1.64	0.00	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	22.52	4.60	2.30	0.92	0.46	0.00	0.00
Sebocyte, donor3	11378-118B1	8.86	2.47	1.24	0.41	0.21	0.00	0.00
Sertoli Cells, donor1	11255-116F4	48.04	9.94	0.00	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	45.19	14.12	0.00	0.00	2.82	2.82	2.82
Skeletal Muscle Cells, donor1	11281-116I3	47.42	7.30	2.46	0.62	1.76	0.97	0.35
Skeletal Muscle Cells, donor2	11358-117H8	10.12	2.17	0.00	0.00	0.72	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	24.25	5.85	0.00	0.00	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	56.71	11.31	4.24	0.63	0.79	0.47	0.31
Skeletal Muscle Cells, donor5	11455-119A6	55.30	12.34	2.68	0.59	1.04	0.45	0.15
Skeletal Muscle Cells, donor6	11459-119B1	60.18	14.16	3.54	1.54	1.39	0.15	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	72.45	17.26	5.17	1.51	3.02	2.02	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	53.37	8.99	2.14	3.57	2.00	1.14	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	62.20	16.27	4.07	2.58	2.48	1.49	0.69
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	51.14	12.64	3.54	0.76	2.11	1.43	0.84
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	19.54	2.17	0.00	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	15.69	3.30	0.96	0.00	0.14	0.00	0.00
Skin - palm, donor1	10286-104F7	220.26	13.43	13.43	2.69	0.00	8.06	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	22.63	5.05	1.73	0.00	0.00	0.14	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	732.83	101.42	28.63	1.64	0.00	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	31.03	5.84	2.60	0.13	0.65	0.13	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	44.76	9.87	1.53	0.70	1.39	1.11	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	38.40	9.00	1.27	0.84	0.84	0.56	0.70
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	289.89	67.87	24.32	5.50	2.75	1.48	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	32.53	6.00	1.72	1.20	1.87	1.27	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	10.49	0.62	0.62	0.00	1.85	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	107.61	15.79	5.34	1.56	1.11	0.44	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	22.34	2.94	1.18	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	17.68	5.75	0.44	0.00	0.22	0.00	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	20.87	1.58	0.00	0.00	0.00	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	26.27	4.64	1.55	1.55	0.00	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	41.03	6.00	1.00	1.00	1.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	17.57	4.13	1.06	0.00	0.00	0.13	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	24.83	5.32	1.11	4.43	4.21	1.11	1.11
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	19.72	6.91	1.28	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	48.19	9.44	2.60	0.00	0.65	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	51.68	13.58	4.73	0.89	1.48	0.00	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	32.46	7.26	1.57	1.00	0.43	0.43	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	10.57	0.98	0.81	0.16	0.49	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	33.18	3.65	1.22	0.30	2.44	0.61	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	18.69	3.28	0.25	0.00	0.25	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	0.00	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	16.69	1.91	0.48	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	52.65	10.91	2.51	0.74	0.59	0.59	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	47.57	6.67	1.72	1.29	0.43	0.22	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	43.14	7.87	2.10	1.26	0.52	0.52	0.52
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	15.62	5.10	1.70	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	18.32	3.23	1.08	0.00	0.00	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	17.33	4.78	1.49	0.00	0.00	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	20.48	1.02	1.02	0.34	1.37	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	60.62	6.75	1.73	1.10	3.46	1.57	0.55
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	43.88	8.35	6.04	0.70	0.60	0.91	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	29.81	9.56	2.05	0.68	2.50	1.82	1.14
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	18.11	3.62	1.21	0.00	1.21	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	68.62	16.43	3.97	2.38	3.97	0.79	1.06
Smooth Muscle Cells - Prostate, donor1	11257-116F6	58.32	7.72	3.86	0.93	1.46	0.40	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	45.58	8.01	3.01	2.75	2.63	0.88	0.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	26.38	3.04	1.78	0.25	0.76	0.51	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	38.30	4.37	1.21	0.00	0.45	0.45	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	15.00	0.75	3.00	0.00	0.00	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	12.92	11.63	1.29	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	19.53	4.65	1.40	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	20.20	8.58	1.51	0.50	1.51	1.01	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	17.86	5.95	1.25	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	8.55	1.47	0.00	0.00	0.00	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	67.23	9.33	3.50	0.42	0.50	0.33	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	37.84	5.14	0.47	0.47	0.47	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	10.65	2.59	0.72	0.14	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	18.87	6.63	0.76	0.51	0.76	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	13.73	1.32	0.75	0.00	0.19	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	58.41	11.32	2.52	1.96	2.93	1.54	0.98
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	27.65	3.94	1.01	0.42	0.92	0.42	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	11.90	0.00	1.43	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	10.03	2.69	0.24	0.00	0.24	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	57.23	11.71	2.65	0.22	1.77	0.88	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	27.79	5.27	3.22	0.00	0.88	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	46.45	5.05	1.55	1.36	1.36	0.78	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	37.02	5.29	2.12	1.06	0.79	1.32	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	62.49	8.93	0.37	1.12	1.49	1.49	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	49.23	6.47	1.44	3.59	2.52	0.72	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	37.19	9.37	1.42	0.57	0.28	0.85	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	57.50	10.63	1.58	0.79	3.54	1.97	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	44.70	4.83	0.51	3.05	0.25	0.76	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	39.13	3.59	3.19	1.20	0.40	0.40	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	37.20	4.18	0.84	1.25	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	38.04	2.29	1.38	0.46	1.38	0.00	0.92
Synoviocyte, donor1	11291-117A4	44.61	11.61	1.68	0.84	1.18	0.34	0.50
Synoviocyte, donor2	11368-117I9	27.16	3.18	1.68	2.51	1.17	0.67	0.34
Synoviocyte, donor3	11440-118H9	21.67	2.68	0.89	1.56	1.56	1.34	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	33.59	2.14	0.71	0.71	0.36	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	19.82	3.96	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	25.24	5.33	0.23	0.00	0.23	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	23.80	3.80	0.65	0.22	0.22	0.29	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	12.37	1.55	0.39	0.39	0.00	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	12.03	1.15	0.57	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	85.38	20.55	3.81	1.97	2.58	2.09	0.74
Urethra, donor2	10319-105A4	160.06	17.98	7.19	12.59	0.00	1.80	0.00
Urothelial Cells, donor1	11520-119H8	8.24	1.33	0.53	0.00	0.00	0.00	0.27
Urothelial Cells, donor2	11600-120H7	13.62	1.60	0.00	0.00	0.40	0.40	0.00
Urothelial Cells, donor3	11681-122H7	11.46	1.38	0.46	0.00	0.23	0.00	0.23
Urothelial cells, donor0	11216-116B1	35.66	5.35	1.78	0.22	3.34	0.67	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	193.97	15.13	0.00	0.89	0.00	0.89	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	238.75	21.44	4.29	0.00	1.43	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	125.27	5.48	1.37	2.05	0.68	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	192.14	15.15	3.44	1.38	0.69	1.03	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	180.12	18.59	1.74	0.00	0.58	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	194.71	16.66	4.16	0.00	1.04	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	202.83	10.10	1.84	0.92	0.00	1.84	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	132.37	6.39	0.00	3.65	0.91	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	75.37	23.56	4.44	2.96	2.22	1.60	1.11
Wilms' tumor cell line:HFWT	10597-108E3	86.24	16.72	5.28	3.52	0.88	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	62.85	13.97	3.63	3.35	1.68	2.23	0.56
achilles tendon, donor2	10292-104G4	130.19	14.47	6.20	2.07	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	91.27	48.44	3.57	9.69	9.43	6.63	2.04
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	149.98	38.08	5.57	3.71	5.11	3.95	1.86
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	167.02	53.42	5.22	7.24	4.15	2.14	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	115.10	44.08	4.08	8.98	9.25	7.62	1.09
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	141.67	39.07	4.50	11.52	10.40	6.18	3.65
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	96.01	24.95	2.54	0.85	0.85	0.42	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	94.46	30.76	3.81	5.72	1.91	1.63	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	118.09	34.37	3.97	2.20	1.76	0.88	1.76
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	118.02	31.85	2.45	8.98	2.86	2.04	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	96.30	33.01	4.27	8.15	3.88	0.78	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	55.38	13.43	2.21	2.02	2.76	1.66	1.66
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	183.32	50.71	7.80	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	95.51	27.89	3.25	5.58	5.58	4.88	0.93
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	143.69	47.64	4.40	6.21	6.47	5.70	2.59
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	142.32	39.16	4.09	12.27	12.86	8.18	4.09
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	92.49	33.46	2.79	2.79	1.86	0.93	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	97.47	19.33	2.47	2.06	1.23	1.23	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	66.61	13.81	1.84	0.61	0.61	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	98.57	30.72	2.99	7.25	2.13	3.84	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	111.31	31.24	3.94	1.82	3.64	1.52	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	131.91	35.87	5.54	2.89	1.93	0.72	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	77.51	27.84	1.11	4.23	4.01	2.45	1.56
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	116.74	32.35	2.67	1.00	3.34	1.67	1.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	183.96	29.73	5.57	1.86	1.86	1.86	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	134.84	26.74	3.01	4.14	4.90	3.01	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	147.41	43.18	6.98	2.62	3.05	1.31	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	138.71	24.37	3.75	0.00	3.75	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	80.31	17.19	2.83	3.30	2.12	1.65	0.71
adipose tissue, adult, pool1	10010-101C1	78.96	10.39	2.64	0.31	2.48	1.24	0.47
adipose, donor1	10184-103D4	201.72	35.77	3.52	11.14	15.25	7.62	5.28
adipose, donor2	10185-103D5	159.77	15.00	6.08	1.62	2.03	0.41	0.00
adipose, donor3	10186-103D6	124.71	31.31	6.26	4.63	2.72	1.91	0.27
adipose, donor4	10187-103D7	95.34	24.27	10.40	7.80	6.93	4.33	3.47
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	109.21	22.88	11.36	2.37	2.84	1.26	0.79
adrenal gland, adult, pool1	10081-102A9	47.29	10.91	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	78.71	10.67	5.34	2.67	2.13	0.93	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	66.10	20.72	3.57	4.29	2.14	2.50	0.36
amniotic membrane cells, donor1	12235-129G3	44.52	9.27	2.78	0.46	0.46	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	38.88	6.76	2.03	0.34	0.34	0.68	0.00
amniotic membrane cells, donor3	12237-129G5	36.83	8.54	2.06	0.88	1.18	1.18	0.29
amygdala - adult, donor10196	10167-103B5	131.62	14.23	9.49	7.11	4.74	3.56	0.00
amygdala, adult, donor10252	10151-102I7	104.02	17.24	5.68	9.94	3.85	2.64	1.01
amygdala, newborn, donor10223	10360-105E9	90.05	17.43	3.23	2.90	2.90	1.94	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	77.42	7.39	3.31	1.53	0.64	0.64	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	80.31	20.52	5.52	5.74	2.43	1.76	1.10
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	262.22	75.49	6.68	13.03	2.00	1.34	0.67
aorta, adult, pool1	10052-101G7	61.78	7.06	4.31	2.16	1.18	0.59	0.39
appendix, adult	10189-103D9	227.05	35.32	6.99	1.16	1.94	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	87.70	24.08	3.10	5.50	4.82	2.06	1.03
artery, adult	10190-103E1	63.86	6.79	2.72	1.36	5.43	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	112.13	25.35	2.17	1.59	2.17	0.87	1.01
b cell line:RPMI1788	10427-106D4	101.56	28.10	6.39	4.91	3.72	2.83	0.74
basal cell carcinoma cell line:TE 354.T	10702-109G9	40.23	7.21	2.77	0.28	1.11	0.55	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	103.70	33.24	2.78	2.98	2.18	0.99	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	77.66	16.74	3.35	1.84	3.68	3.18	1.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	63.19	12.86	2.80	3.91	2.80	0.00	2.24
bladder, adult, pool1	10011-101C2	86.04	7.60	4.24	1.09	1.63	2.28	0.33
blood, adult, pool1	10053-101G8	42.08	11.07	2.21	0.00	0.00	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	45.39	13.70	2.57	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	107.30	18.22	4.72	10.80	11.47	7.42	2.70
brain, adult, donor1	10084-102B3	75.86	7.18	3.08	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	82.96	11.92	8.13	3.23	3.79	2.90	1.00
brain, fetal, pool1	10085-102B4	69.46	10.69	2.67	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	69.38	19.16	3.63	3.30	2.97	1.32	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	189.98	26.09	7.74	3.00	2.37	2.12	0.62
breast, adult, donor1	10080-102A8	56.19	13.26	0.63	0.00	0.63	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	63.65	7.37	4.07	4.19	3.43	2.29	1.14
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	100.50	23.50	4.95	7.11	3.09	2.16	1.24
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	100.15	16.35	6.91	3.45	2.53	0.69	1.84
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	51.56	16.22	4.84	2.91	5.08	3.15	1.21
carcinoid cell line:NCI-H1770	10703-109H1	108.61	19.28	6.58	3.76	3.76	0.94	0.94
carcinoid cell line:NCI-H727	10735-110B6	67.16	15.86	2.84	1.64	1.75	1.53	0.33
carcinoid cell line:SK-PN-DW	10719-109I8	59.58	28.84	2.54	1.58	2.22	2.54	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	148.79	32.47	2.66	6.92	5.59	4.26	2.93
caudate nucleus - adult, donor10196	10177-103C6	175.00	24.18	24.18	3.45	2.30	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	102.24	17.07	6.19	11.55	6.02	3.68	0.67
caudate nucleus, adult, donor10258	10379-105H1	141.37	12.23	5.35	6.11	3.82	2.29	1.53
caudate nucleus, newborn, donor10223	10354-105E3	139.53	23.44	5.86	2.20	1.46	2.20	0.37
cerebellum - adult, donor10196	10173-103C2	393.29	61.18	32.05	14.57	0.00	8.74	0.00
cerebellum, adult, donor10252	10166-103B4	285.25	40.57	13.88	20.28	13.88	6.83	2.56
cerebellum, adult, pool1	10083-102B2	97.62	11.04	5.17	5.86	5.52	0.69	0.34
cerebellum, newborn, donor10223	10357-105E6	252.41	29.06	4.98	7.47	4.98	0.83	2.49
cerebral meninges, adult	10188-103D8	74.63	10.59	3.28	1.76	1.01	0.50	0.00
cerebrospinal fluid, donor2	10294-104G6	68.70	10.23	2.92	7.31	0.73	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	64.85	17.69	1.73	1.15	1.58	0.72	0.29
cervical cancer cell line:ME-180	10553-107I4	59.49	14.75	1.66	1.16	1.49	0.99	0.33
cervix, adult, pool1	10013-101C4	127.25	13.96	5.35	1.89	2.52	1.47	0.63
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	40.13	6.41	1.53	0.70	0.42	0.00	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	36.58	5.23	1.31	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	99.05	39.40	4.72	3.48	3.48	2.61	0.87
choriocarcinoma cell line:SCH	10785-110H2	64.69	16.76	2.46	3.57	2.83	2.09	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	53.84	22.77	4.74	1.66	1.19	0.95	0.47
chorionic membrane cells, donor1	12238-129G6	34.48	10.54	2.56	0.57	2.28	0.57	0.00
chorionic membrane cells, donor2	12239-129G7	40.57	10.04	1.49	0.89	1.19	0.10	0.40
chorionic membrane cells, donor3	12240-129G8	40.66	11.54	0.55	2.20	2.20	0.55	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	38.37	21.21	1.01	5.05	2.02	1.01	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	87.02	22.86	3.46	4.42	1.73	1.54	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	86.38	20.49	3.17	2.11	1.27	1.27	0.84
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	82.95	15.41	1.54	2.31	3.08	1.80	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	92.88	15.48	2.90	1.45	3.14	0.97	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	94.27	19.34	1.63	1.02	5.29	2.24	1.02
chronic myelogenous leukemia cell line:K562	10454-106G4	108.36	19.43	1.77	2.65	3.24	2.36	0.88
chronic myelogenous leukemia cell line:KU812	10409-106B4	360.18	72.98	6.52	6.26	4.69	4.69	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	62.17	16.00	3.20	4.11	4.11	2.29	0.91
clear cell carcinoma cell line:TEN	10636-108I6	77.56	36.61	4.51	2.43	1.21	0.52	0.35
colon carcinoma cell line:CACO-2	10513-107D9	66.26	26.18	3.48	1.10	1.10	0.18	0.37
colon carcinoma cell line:COLO-320	10420-106C6	85.90	36.87	4.94	3.42	2.66	1.90	0.38
colon, adult, donor1	10082-102B1	57.12	5.95	2.38	0.00	0.00	2.38	0.00
colon, adult, pool1	10014-101C5	86.25	10.69	3.64	1.18	0.47	0.94	0.35
colon, fetal, donor1	10070-101I7	74.16	14.83	2.47	0.00	1.24	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	550.02	114.59	13.75	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	100.15	0.00	50.07	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	254.11	61.62	11.47	3.82	1.27	2.97	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	127.84	29.88	6.34	1.36	1.51	1.36	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	134.24	33.14	5.92	3.67	3.10	1.83	0.14
corpus callosum, adult, pool1	10042-101F6	129.14	17.80	7.96	2.43	2.10	0.88	0.33
cruciate ligament, donor2	10295-104G7	166.96	9.73	6.48	8.92	0.00	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	81.86	12.04	0.80	0.00	1.61	2.41	0.00
diencephalon, adult	10193-103E4	78.24	9.36	6.00	3.36	3.84	0.24	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	83.12	49.14	2.53	10.10	11.48	5.28	2.07
ductal cell carcinoma cell line:KLM-1	10438-106E6	122.58	31.80	6.67	0.26	3.59	1.54	1.03
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	52.48	21.91	6.02	3.85	3.37	2.89	0.00
ductus deferens, adult	10196-103E7	122.59	25.42	2.99	1.50	1.00	1.00	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	125.30	10.08	1.44	7.20	1.44	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	165.52	25.01	3.68	6.62	5.89	1.47	0.74
dura mater, adult, donor1	10041-101F5	167.90	13.71	14.95	2.15	1.57	0.91	0.25
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	85.05	63.29	6.22	1.78	0.67	0.44	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	86.26	33.67	5.88	1.72	1.43	2.01	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	64.74	14.18	1.85	0.62	0.00	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	55.70	9.38	2.72	1.51	0.91	0.61	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	74.72	10.50	2.16	0.93	0.31	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	70.93	7.88	6.57	0.00	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	93.52	20.45	4.36	2.01	1.34	1.34	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	103.49	16.67	6.34	6.16	5.44	3.26	1.81
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	55.96	18.17	2.25	3.06	3.86	1.77	0.96
epidermoid carcinoma cell line:A431	10426-106D3	84.04	28.23	5.67	1.11	3.33	2.33	0.44
epidermoid carcinoma cell line:Ca Ski	10431-106D8	113.51	30.47	3.30	2.75	3.19	1.87	0.66
epididymis, adult	10197-103E8	140.66	20.51	4.60	3.14	0.84	1.05	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	83.74	13.31	3.90	5.50	3.02	4.44	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	66.46	9.04	3.15	1.18	1.57	1.18	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	68.01	31.45	4.19	4.32	8.39	2.62	2.23
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	65.06	32.87	3.94	6.59	8.56	3.54	0.69
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	61.39	30.25	3.47	7.06	7.84	3.25	1.34
esophagus, adult, pool1	10015-101C6	61.16	7.01	2.55	1.06	0.64	1.27	0.74
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	179.34	40.83	10.90	2.25	2.76	1.75	0.13
eye - muscle inferior rectus, donor1	10272-104E2	210.07	16.90	12.07	4.83	0.00	7.24	0.00
eye - muscle lateral, donor2	10298-104H1	86.27	4.21	4.21	6.31	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	77.39	7.44	1.49	0.00	1.49	1.49	0.00
eye - muscle superior, donor2	10297-104G9	107.77	18.34	2.29	4.59	2.29	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	96.19	14.57	5.83	2.91	0.00	1.46	1.46
eye, fetal, donor1	10054-101G9	46.52	7.37	2.03	1.78	3.81	1.53	0.76
fibrosarcoma cell line:HT-1080	10758-110E2	48.85	14.36	2.56	3.46	2.18	1.03	0.64
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	63.87	15.91	3.09	3.32	2.37	0.95	0.71
frontal lobe, adult, pool1	10040-101F4	153.78	20.92	13.70	2.63	3.66	2.16	0.75
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	113.19	29.72	5.70	8.71	9.61	4.80	1.80
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	83.57	6.58	5.94	1.28	0.64	0.55	0.46
gall bladder, adult	10198-103E9	106.47	14.97	4.10	1.69	1.45	0.00	0.00
gamma delta positive T cells, donor1	11937-126A2	158.37	20.94	6.44	1.61	2.15	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	169.94	21.29	5.60	1.12	0.37	0.37	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	40.98	13.52	0.63	2.32	2.11	1.27	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	99.61	13.93	4.26	6.19	3.09	0.77	0.58
gastric cancer cell line:AZ521	10549-107H9	99.19	44.43	5.74	3.93	2.79	1.48	0.33
gastric cancer cell line:GSS	10560-108A2	68.64	10.07	1.83	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	88.18	33.35	1.60	7.08	6.85	2.28	1.37
giant cell carcinoma cell line:LU65	10487-107B1	68.16	12.85	3.79	0.57	4.02	2.75	0.80
giant cell carcinoma cell line:Lu99B	10433-106E1	155.63	15.54	10.50	2.80	1.40	0.98	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	66.59	19.70	2.49	2.24	3.24	1.00	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	65.34	24.28	4.22	2.22	2.43	2.01	0.53
glioblastoma cell line:A172, tech_rep2	10444-106F3	58.98	24.86	2.53	3.23	1.69	2.67	0.70
glioblastoma cell line:T98G	10485-107A8	58.50	11.81	2.54	2.76	1.88	1.10	0.22
glioma cell line:GI-1	10413-106B8	56.23	18.74	0.59	1.46	1.76	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	154.53	22.60	8.02	2.92	0.73	2.19	0.73
globus pallidus, adult, donor10252	10161-103A8	153.54	16.60	7.57	8.30	4.15	3.42	0.73
globus pallidus, adult, donor10258	10367-105F7	194.43	26.01	15.06	2.74	2.74	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	82.07	10.66	4.80	0.00	1.07	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	513.90	115.02	9.79	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	65.57	21.86	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	26.13	5.23	5.23	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	52.16	15.68	1.92	0.96	1.28	0.64	0.64
hIPS +CCl2, biol_rep1	14383-156B9	141.41	31.22	7.80	3.67	5.51	0.92	3.21
hIPS +CCl2, biol_rep2	14384-156C1	146.32	40.70	4.12	2.29	6.40	2.74	1.37
hIPS +CCl2, biol_rep3	14385-156C2	150.07	29.63	5.15	1.29	3.86	3.86	3.86
hIPS, biol_rep1	14380-156B6	214.16	45.99	4.31	0.00	0.00	0.00	1.44
hIPS, biol_rep2	14381-156B7	159.81	45.27	4.80	2.06	2.74	4.80	4.80
hIPS, biol_rep3	14382-156B8	110.35	22.07	8.83	3.31	8.83	3.31	1.10
hairy cell leukemia cell line:Mo	10712-109I1	87.07	19.25	3.74	5.75	4.31	2.87	0.57
heart - mitral valve, adult	10205-103F7	105.54	13.15	4.48	2.69	1.20	0.00	0.30
heart - pulmonic valve, adult	10206-103F8	107.99	9.67	3.92	5.49	6.28	3.66	1.31
heart - tricuspid valve, adult	10207-103F9	135.72	22.48	5.00	5.83	4.16	1.67	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	43.26	8.57	1.84	5.71	2.65	1.63	0.41
heart, adult, diseased, donor1	10051-101G6	45.99	4.68	0.85	0.43	0.43	0.85	0.00
heart, adult, pool1	10016-101C7	46.00	4.37	3.22	0.23	0.23	0.00	0.00
heart, fetal, pool1	10046-101G1	128.86	17.15	3.08	1.03	2.98	1.33	0.41
hepatic mesenchymal tumor cell line:LI90	10778-110G4	53.68	7.10	2.47	0.93	1.23	0.93	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	67.78	22.59	1.19	1.19	1.19	2.38	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	52.49	33.92	3.54	6.96	5.19	3.20	1.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	56.56	38.96	3.16	5.34	6.68	3.52	1.58
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	68.92	39.41	4.65	6.57	7.07	4.95	1.52
hepatoma cell line:Li-7	10484-107A7	60.39	11.12	1.67	1.11	1.56	1.45	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	88.24	30.45	3.12	3.92	3.12	1.51	1.11
hippocampus - adult, donor10196	10169-103B7	136.27	22.71	13.25	6.62	1.89	2.84	0.00
hippocampus, adult, donor10252	10153-102I9	102.46	19.39	6.33	10.82	5.10	2.65	1.22
hippocampus, adult, donor10258	10374-105G5	149.39	18.42	7.97	3.98	2.99	1.49	3.49
hippocampus, newborn, donor10223	10363-105F3	104.69	12.69	6.70	0.35	0.70	0.35	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	129.39	66.53	4.27	2.44	6.71	2.44	2.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	69.31	31.02	2.75	3.53	4.71	1.77	2.55
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	102.57	35.04	5.59	3.30	4.06	2.29	2.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	157.32	27.07	5.64	1.69	1.69	1.13	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	139.95	33.05	2.32	5.68	11.88	3.36	3.61
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	145.77	20.88	6.83	1.90	4.18	0.76	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	193.27	40.00	8.47	2.63	3.21	1.46	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	161.57	30.59	7.11	3.23	4.95	1.51	1.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	161.82	27.94	9.59	0.83	1.25	0.83	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	92.59	28.65	1.89	0.95	1.66	0.47	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	100.13	25.39	5.30	5.14	3.54	2.41	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	74.74	22.22	5.39	0.67	0.67	1.35	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	83.88	33.96	3.91	3.91	6.26	1.72	2.03
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	85.49	38.32	5.40	4.91	6.88	4.42	4.42
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	126.55	45.38	2.62	2.62	7.85	1.75	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	162.46	19.66	6.11	3.05	4.58	2.86	1.15
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	157.86	26.16	3.05	1.31	7.41	3.92	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	218.90	44.48	4.00	2.00	3.50	1.00	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	133.76	16.39	6.03	3.39	2.45	1.70	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	145.96	21.37	7.73	1.36	2.27	0.91	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	187.31	16.91	5.95	3.45	3.45	0.31	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	78.71	17.47	1.96	2.29	3.10	1.63	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	69.96	17.71	3.77	0.87	2.61	1.16	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	93.26	19.43	2.09	0.60	1.20	1.79	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	90.34	38.80	3.88	3.88	7.02	1.85	2.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	87.01	37.37	5.14	2.57	4.85	2.57	2.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	128.21	48.59	5.72	4.49	1.63	2.45	2.04
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	110.55	29.93	3.87	1.41	5.28	2.11	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	113.71	20.27	4.75	1.90	4.75	1.90	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	115.00	22.09	6.05	0.61	2.12	1.82	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	146.35	24.82	10.86	2.59	4.14	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	136.82	27.23	4.65	1.99	0.00	1.33	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	133.14	17.44	5.90	0.77	1.80	1.03	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	86.66	26.84	1.79	2.30	3.32	2.56	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	134.79	31.80	3.79	0.76	2.27	1.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	110.23	20.16	2.35	1.34	2.35	1.01	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	95.15	45.16	5.55	5.07	7.00	1.45	1.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	101.61	59.72	7.58	4.46	5.35	2.67	2.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	96.59	44.88	5.85	4.39	3.90	2.44	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	150.98	23.84	7.03	3.97	5.81	1.53	1.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	419.67	149.65	6.51	9.76	29.28	9.76	19.52
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	188.31	30.12	3.97	1.32	4.96	2.32	2.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	159.81	33.39	7.11	1.64	4.93	2.74	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	158.14	24.61	10.49	1.81	3.26	0.72	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	162.99	26.33	6.05	2.85	3.20	1.07	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	97.86	26.25	4.77	2.39	1.19	3.58	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	140.44	38.60	6.77	1.76	2.30	1.08	0.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	90.25	24.78	4.58	1.89	1.35	1.35	0.27
immature langerhans cells, donor1	11904-125F5	139.96	37.05	11.38	1.70	0.48	0.48	0.48
immature langerhans cells, donor2	11905-125F6	143.38	30.89	9.51	0.79	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	129.55	14.86	9.65	0.66	1.14	0.38	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	39.67	8.13	0.65	1.30	1.63	0.98	0.65
kidney, adult, pool1	10017-101C8	57.57	12.22	1.40	1.60	2.00	1.60	0.40
kidney, fetal, pool1	10045-101F9	107.02	17.61	2.76	0.42	0.85	0.50	0.35
large cell lung carcinoma cell line:IA-LM	10509-107D5	107.37	33.66	6.39	1.14	0.57	0.57	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	28.20	8.71	1.24	0.14	1.24	0.00	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	40.37	8.81	0.92	0.55	1.10	0.00	0.00
left atrium, adult, donor1	10079-102A7	42.50	7.08	1.63	1.09	4.36	0.54	0.54
left ventricle, adult, donor1	10078-102A6	47.53	2.02	1.52	0.00	2.53	2.02	1.52
leiomyoblastoma cell line:G-402	10721-110A1	94.12	12.59	6.57	3.01	1.09	1.09	0.55
leiomyoma cell line:10964C	10569-108B2	15.81	4.67	2.87	0.00	0.72	0.36	0.36
leiomyoma cell line:15242A	10570-108B3	18.48	5.43	2.72	0.00	0.54	0.54	0.00
leiomyoma cell line:15425	10571-108B4	29.14	6.31	2.43	0.97	2.19	0.24	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	31.75	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	99.33	28.23	3.14	1.05	0.00	1.05	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	106.61	33.06	3.54	8.26	3.78	3.54	0.83
liposarcoma cell line:KMLS-1	10782-110G8	45.46	7.65	1.56	1.72	0.47	0.78	0.62
liposarcoma cell line:SW 872	10726-110A6	54.34	15.35	3.29	1.58	1.34	1.22	0.73
liver, adult, pool1	10018-101C9	36.63	7.78	2.92	0.32	1.78	0.81	0.97
liver, fetal, pool1	10086-102B5	41.39	9.41	0.94	0.94	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	105.58	19.54	9.19	6.42	5.25	3.21	1.02
locus coeruleus, adult, donor10252	10165-103B3	88.22	16.06	4.43	9.60	4.61	1.11	1.29
locus coeruleus, adult, donor10258	10375-105G6	90.57	13.26	4.51	3.10	0.28	1.13	1.97
locus coeruleus, newborn, donor10223	10362-105F2	136.70	35.33	4.63	3.36	2.94	3.79	0.84
lung adenocarcinoma cell line:A549	10499-107C4	38.20	8.58	2.08	0.28	0.14	0.28	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	65.49	15.17	1.38	0.00	0.00	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	67.49	12.39	5.14	1.05	1.98	1.05	0.26
lung, adult, pool1	10019-101D1	69.70	6.50	2.13	0.95	0.59	0.59	0.12
lung, fetal, donor1	10068-101I5	381.59	47.09	7.71	0.86	0.29	2.00	0.29
lung, right lower lobe, adult, donor1	10075-102A3	123.72	14.66	2.29	5.04	2.29	3.21	1.37
lymph node, adult, donor1	10077-102A5	68.16	6.63	2.37	0.95	3.31	1.89	0.47
lymphangiectasia cell line:DS-1	10727-110A7	61.59	15.34	1.75	2.85	1.75	0.88	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	77.43	43.92	2.87	3.02	2.11	1.66	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	110.43	38.23	7.65	0.85	1.70	2.55	1.70
mature adipocyte, donor1	12231-129F8	89.69	19.09	11.10	0.44	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	63.92	16.19	6.64	0.83	0.21	0.21	0.42
mature adipocyte, donor3	12233-129G1	118.06	19.68	7.59	1.19	0.00	0.24	0.47
mature adipocyte, donor4	12234-129G2	124.24	27.90	6.05	0.00	0.26	0.26	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	81.48	25.02	3.81	1.19	2.38	0.48	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	127.47	24.82	13.54	10.15	13.54	2.26	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	111.45	22.80	5.89	11.59	6.25	5.15	2.02
medial frontal gyrus, adult, donor10258	10368-105F8	89.59	11.75	8.26	2.22	0.95	2.22	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	132.21	24.31	7.68	3.84	4.26	2.99	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	144.45	24.98	11.64	6.24	16.88	3.88	2.87
medial temporal gyrus, adult, donor10252	10156-103A3	129.88	27.59	6.79	13.79	7.00	4.46	1.27
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	146.40	23.12	9.63	0.00	3.85	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	1636.31	301.43	71.77	330.13	258.37	200.95	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	112.35	15.79	7.90	1.44	1.44	1.44	0.36
medulla oblongata - adult, donor10196	10174-103C3	109.68	15.58	12.98	2.60	0.00	0.00	1.30
medulla oblongata, adult, donor10252	10155-103A2	105.27	17.96	5.73	7.89	4.33	2.48	1.70
medulla oblongata, adult, pool1	10038-101F2	85.46	10.12	5.96	0.73	0.57	0.24	0.16
medulla oblongata, newborn, donor10223	10361-105F1	82.63	19.09	3.82	1.74	1.39	1.39	0.69
medulloblastoma cell line:D283 Med	10838-111E1	212.56	74.62	13.06	15.94	8.64	8.19	1.99
medulloblastoma cell line:ONS-76	10759-110E3	48.42	12.96	2.08	2.08	2.32	1.47	0.49
melanoma cell line:COLO 679	10514-107E1	36.66	25.59	1.01	0.72	0.86	0.57	0.14
melanoma cell line:G-361	10465-106H6	32.58	14.39	2.99	2.17	2.99	0.54	0.81
meningioma cell line:HKBMM	10691-109F7	47.76	5.79	1.99	1.09	1.63	0.36	1.09
merkel cell carcinoma cell line:MKL-1	10843-111E6	174.47	69.61	5.29	4.41	5.29	1.76	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	118.47	30.59	4.93	2.33	5.18	2.07	1.81
mesenchymal precursor cell - adipose, donor1	11747-123G1	36.06	10.59	2.76	1.07	1.69	0.92	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	35.08	6.91	1.09	0.18	1.27	0.36	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	29.82	7.87	2.48	0.41	2.48	0.83	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	30.48	4.50	1.69	0.98	0.70	0.70	0.56
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	31.58	5.39	1.73	0.77	1.54	0.77	1.16
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	34.01	10.41	0.69	2.08	0.00	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	18.54	3.60	1.37	1.03	0.17	0.17	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	29.56	5.64	1.73	0.35	1.27	0.35	0.46
mesenchymal precursor cell - cardiac, donor3	11754-123G8	31.17	7.30	1.72	0.80	1.33	0.93	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	36.19	7.43	1.22	1.49	1.62	1.08	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	37.13	8.82	2.99	1.28	2.13	1.28	0.71
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	46.77	5.27	1.32	1.98	0.00	0.66	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	38.61	7.61	2.21	1.25	0.69	0.83	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	45.03	5.24	1.75	2.09	1.40	1.75	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	29.81	4.29	1.22	0.82	1.22	1.02	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	44.21	7.55	2.52	2.52	0.36	1.08	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	21.21	5.69	1.97	0.52	0.83	0.52	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	31.92	11.40	1.37	0.68	0.68	0.46	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	65.87	22.24	2.52	0.84	2.10	3.36	1.68
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	27.35	6.43	2.09	0.60	0.90	0.90	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	25.82	6.74	1.31	1.40	1.49	0.70	0.70
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	40.13	8.47	1.47	0.74	0.00	0.37	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	51.79	12.30	2.86	2.29	0.57	0.57	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	57.68	14.31	2.11	4.21	3.37	2.53	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	32.42	6.39	1.37	0.00	0.46	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	32.74	4.09	2.30	0.77	1.02	0.26	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	31.41	5.24	2.09	0.79	1.05	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	30.19	3.08	1.85	0.62	2.46	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	28.95	4.94	1.65	0.24	1.65	0.71	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	35.20	7.11	1.35	0.34	1.35	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	36.55	5.11	0.79	0.79	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	27.80	4.63	2.32	0.93	0.93	1.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	193.21	48.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	36.34	4.33	2.60	1.44	1.44	0.87	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	35.47	4.02	1.34	1.12	0.89	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	32.93	4.09	2.64	0.72	0.48	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	38.13	6.60	3.67	0.00	0.73	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	29.54	4.03	2.69	0.67	1.34	0.67	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	29.07	4.09	2.05	1.23	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	30.93	4.30	3.87	1.29	1.29	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	38.28	19.14	2.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	30.99	5.16	0.00	0.00	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	40.92	6.50	2.60	0.97	0.00	0.32	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	49.47	2.91	4.36	1.45	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	36.25	3.20	3.20	1.07	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	34.35	7.36	2.45	0.82	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	31.49	4.66	1.94	1.17	1.17	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	33.58	2.10	0.00	2.10	0.00	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	48.68	4.97	1.99	0.00	0.99	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	52.44	4.77	0.00	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	39.14	4.15	0.59	0.00	0.00	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	36.55	8.53	1.22	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	41.17	5.07	3.17	1.90	0.00	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	30.70	2.41	1.38	0.00	0.34	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	27.94	6.45	4.30	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	35.93	0.00	3.99	0.00	3.99	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	17.22	0.00	0.00	0.00	0.00	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	19.15	2.44	0.41	0.81	0.41	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	15.09	3.97	0.00	0.79	1.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	20.04	4.72	1.18	1.77	1.77	0.59	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	20.26	4.36	0.00	0.62	0.31	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	26.73	4.01	1.34	0.00	0.00	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	26.02	7.10	1.18	0.00	1.18	1.18	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	53.93	10.27	2.57	2.57	7.70	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	35.11	6.88	3.44	0.69	5.51	0.69	2.75
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	31.17	8.41	1.48	2.97	3.96	2.47	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	32.52	4.49	0.00	1.12	3.36	3.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	26.08	5.72	3.82	2.54	2.54	2.54	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	16.12	3.22	0.81	0.40	2.42	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	17.44	4.36	4.36	2.18	4.36	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	10.14	5.07	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	23.67	6.07	0.00	1.21	0.00	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	9.04	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	20.59	4.12	1.65	0.82	1.65	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	24.41	3.77	0.60	0.00	0.60	0.40	0.79
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	26.93	5.84	0.32	1.30	1.30	0.65	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	16.30	2.04	0.00	2.04	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	35.59	6.96	3.09	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	40.87	6.38	5.43	1.18	0.47	0.71	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	150.12	36.60	11.58	4.17	4.17	2.09	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	38.46	17.09	0.00	0.00	4.27	17.09	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	29.28	11.61	1.44	0.72	0.82	0.51	0.21
mesothelioma cell line:Mero-25	10850-111F4	30.18	8.40	1.36	1.59	1.36	0.68	0.23
mesothelioma cell line:Mero-41	10851-111F5	51.58	9.05	5.87	1.22	2.69	1.47	0.49
mesothelioma cell line:Mero-48a	10852-111F6	29.67	9.52	1.77	0.89	2.88	0.66	0.00
mesothelioma cell line:Mero-82	10853-111F7	50.72	23.13	1.58	3.15	4.73	2.10	2.37
mesothelioma cell line:Mero-83	10854-111F8	48.34	23.49	1.87	2.21	3.40	1.70	1.53
mesothelioma cell line:Mero-84	10855-111F9	29.57	6.07	1.77	0.25	1.01	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	39.55	9.94	1.04	1.66	1.24	0.41	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	36.94	11.60	1.82	1.82	2.65	0.99	0.17
mesothelioma cell line:NCI-H226	10846-111E9	38.91	17.74	2.71	2.71	2.90	2.17	1.63
mesothelioma cell line:NCI-H2452	10848-111F2	36.04	7.69	1.37	1.02	1.37	2.39	0.34
mesothelioma cell line:NCI-H28	10845-111E8	38.17	12.72	3.05	1.27	4.07	0.25	0.76
mesothelioma cell line:No36	10857-111G2	27.73	9.79	2.28	1.30	2.28	0.98	0.33
mesothelioma cell line:ONE58	10858-111G3	28.45	15.44	0.27	2.98	2.71	1.35	0.27
migratory langerhans cells, donor1	11901-125F2	113.43	10.56	3.07	2.49	0.77	0.38	0.38
migratory langerhans cells, donor2	11902-125F3	84.38	7.45	2.93	0.73	0.00	0.73	0.12
migratory langerhans cells, donor3	11903-125F4	119.71	12.74	5.03	2.33	1.26	0.72	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	56.48	14.69	1.31	2.61	1.96	1.63	1.31
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	54.04	8.48	1.27	2.97	0.85	1.06	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	58.97	14.28	2.30	2.07	1.61	0.69	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	52.14	9.51	1.90	2.28	0.95	0.76	0.95
myelodysplastic syndrome cell line:SKM-1	10772-110F7	108.47	35.11	3.88	2.96	1.48	1.29	0.55
myeloma cell line:PCM6	10474-106I6	68.20	6.52	1.38	1.19	1.38	2.17	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	44.64	19.28	3.04	2.03	1.01	1.01	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	34.13	8.63	1.37	0.78	0.98	0.39	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	17.16	3.68	2.34	0.11	0.33	0.11	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	22.65	3.24	2.50	0.00	0.00	0.07	0.00
nasal epithelial cells, donor2	12227-129F4	28.70	4.97	2.21	0.55	0.00	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	101.92	49.23	4.83	2.76	0.92	0.92	0.23
neuroblastoma cell line:NB-1	10539-107G8	121.23	35.92	5.61	2.25	1.68	2.81	0.56
neuroblastoma cell line:NBsusSR	10607-108F4	40.28	22.35	0.84	4.85	1.48	1.90	1.05
neuroblastoma cell line:NH-12	10555-107I6	152.25	46.03	4.10	12.67	5.59	3.17	1.68
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	119.32	39.85	3.08	13.05	5.93	3.80	0.95
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	110.23	34.69	4.12	6.34	3.64	3.01	0.95
neuroectodermal tumor cell line:TASK1	10774-110F9	105.06	22.54	4.23	5.03	1.81	1.61	0.60
neuroepithelioma cell line:SK-N-MC	10728-110A8	69.93	22.25	1.91	3.81	0.00	2.54	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	44.98	9.58	2.13	0.80	0.53	0.53	0.00
neutrophil PMN, donor1	12133-128D9	89.25	29.75	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	92.96	13.28	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	113.65	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	190.94	39.74	1.86	4.74	3.55	4.57	0.85
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	54.43	7.20	4.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	41.68	8.98	0.96	1.60	0.96	0.64	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	37.05	10.25	1.84	1.05	2.10	0.79	0.26
nucleus accumbens, adult, pool1	10037-101F1	142.58	17.15	11.06	1.69	2.53	1.12	0.56
occipital cortex - adult, donor10196	10172-103C1	181.31	22.66	24.72	6.18	0.00	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	150.01	23.08	7.25	13.15	5.10	2.95	1.88
occipital cortex, newborn, donor10223	10355-105E4	113.55	19.29	8.37	1.09	2.55	1.46	1.09
occipital lobe, adult, donor1	10076-102A4	101.02	16.01	8.66	3.67	0.79	0.26	0.00
occipital lobe, fetal, donor1	10073-102A1	258.75	38.19	12.87	8.15	0.86	1.29	0.00
occipital pole, adult, pool1	10036-101E9	66.15	8.04	6.23	0.08	0.63	0.24	0.16
olfactory region, adult	10195-103E6	108.71	15.48	9.17	12.80	8.79	4.78	3.82
optic nerve, donor1	10277-104E7	282.15	32.02	10.01	4.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	59.57	13.10	3.08	1.59	2.28	1.14	0.57
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	112.24	12.09	5.08	0.55	0.96	0.27	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	90.93	21.67	2.88	4.23	2.03	1.52	1.19
oral squamous cell carcinoma cell line:SAS	10544-107H4	67.80	23.33	1.27	4.04	3.93	1.62	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	45.56	5.00	1.18	1.18	0.88	0.59	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	71.94	23.36	0.00	0.93	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	97.55	29.69	4.03	1.70	1.27	0.85	0.00
ovary, adult, pool1	10020-101D2	76.52	10.83	2.71	0.79	2.01	0.79	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	53.53	9.17	2.75	2.20	2.02	1.47	0.18
pancreas, adult, donor1	10049-101G4	37.63	9.41	0.00	2.82	0.00	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	56.19	19.01	1.68	3.35	2.52	1.12	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	43.78	11.58	1.70	3.41	3.41	2.04	0.51
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	93.22	22.52	2.15	1.16	1.32	0.99	0.33
paracentral gyrus, adult, pool1	10035-101E8	106.99	16.38	8.79	1.28	2.84	0.82	0.37
parietal cortex, adult, donor10258	10373-105G4	115.97	13.21	7.34	7.34	2.94	2.20	2.94
parietal lobe - adult, donor10196	10171-103B9	148.60	18.81	12.23	6.58	9.40	3.76	0.00
parietal lobe, adult, donor10252	10157-103A4	130.55	24.23	7.70	10.26	7.41	3.71	3.42
parietal lobe, adult, pool1	10034-101E7	97.02	11.37	6.79	1.41	2.11	1.41	0.35
parietal lobe, fetal, donor1	10072-101I9	272.52	46.55	7.76	11.64	5.82	0.97	1.94
parietal lobe, newborn, donor10223	10356-105E5	115.15	19.07	10.47	4.86	3.36	1.87	1.12
parotid gland, adult	10199-103F1	62.90	11.72	0.62	0.62	2.47	0.00	0.62
penis, adult	10200-103F2	128.37	10.74	4.83	6.98	4.83	4.30	4.30
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	99.85	14.87	3.72	4.46	3.16	1.67	0.93
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	69.06	13.70	2.77	4.08	2.62	2.48	0.58
pineal gland - adult, donor10196	10179-103C8	175.45	41.28	10.97	3.23	0.00	2.58	0.00
pineal gland, adult, donor10252	10160-103A7	207.87	34.94	8.29	5.92	4.15	3.55	1.18
pineal gland, adult, donor10258	10377-105G8	154.89	14.42	3.14	5.02	2.51	3.76	0.63
pituitary gland - adult, donor10196	10180-103C9	185.16	31.37	20.24	9.11	2.02	5.06	1.01
pituitary gland, adult, donor10252	10162-103A9	293.95	66.19	8.86	5.21	4.69	6.25	0.52
pituitary gland, adult, donor10258	10378-105G9	173.65	22.98	2.55	10.21	7.66	2.55	2.55
placenta, adult, pool1	10021-101D3	64.93	16.34	2.15	0.43	0.97	1.40	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	96.54	24.63	3.05	2.12	2.91	2.25	1.19
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	45.91	12.92	1.71	0.78	0.78	0.31	0.16
pons, adult, pool1	10033-101E6	122.04	19.02	8.95	2.93	3.01	1.89	0.77
postcentral gyrus, adult, pool1	10032-101E5	80.64	12.73	8.11	0.52	1.31	0.61	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	152.67	41.83	10.46	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	44.06	11.02	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	108.37	24.47	5.24	5.97	8.01	3.93	0.87
prostate cancer cell line:PC-3	10439-106E7	159.00	30.13	9.26	10.89	12.16	5.26	2.18
prostate, adult, pool1	10022-101D4	78.45	7.98	3.90	0.63	0.91	0.54	0.09
putamen, adult, donor10196	10176-103C5	153.44	16.76	14.40	14.87	8.73	4.25	2.12
putamen, adult, donor10252	10152-102I8	98.04	9.80	1.96	0.00	1.96	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	131.14	19.67	8.74	4.37	4.37	3.28	3.28
putamen, adult, donor10258, tech_rep2	10372-105G3	89.40	14.01	5.80	7.01	5.56	2.17	0.72
putamen, newborn, donor10223	10365-105F5	169.42	42.73	2.25	3.75	3.00	3.00	1.50
rectal cancer cell line:TT1TKB	10469-106I1	84.08	25.02	3.49	2.62	3.20	4.07	1.16
rectum, fetal, donor1	10067-101I4	147.45	30.60	1.39	6.95	1.39	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	39.01	6.57	2.33	0.21	1.27	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	41.42	3.73	0.83	3.73	2.90	1.24	0.41
retina, adult, pool1	10030-101E3	107.65	13.92	7.16	0.99	2.29	0.60	0.40
retinoblastoma cell line:Y79	10475-106I7	126.00	57.68	5.46	11.95	10.13	5.46	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	92.33	18.69	5.78	5.16	3.07	1.84	0.49
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	152.97	36.56	6.75	4.22	2.81	1.41	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	50.78	8.34	2.27	0.76	0.00	0.76	0.76
salivary acinar cells, donor1	11771-123I7	58.59	7.77	2.75	3.08	4.37	1.78	0.32
salivary acinar cells, donor2	11772-123I8	58.38	7.02	4.41	3.72	4.13	1.10	0.69
salivary acinar cells, donor3	11773-123I9	59.58	5.96	4.63	1.32	1.32	0.66	0.00
salivary gland, adult, pool1	10093-102C3	89.80	12.58	2.29	0.00	1.14	0.57	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	74.03	11.13	2.61	1.69	1.60	1.10	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	57.84	8.82	2.70	2.70	1.06	1.18	0.47
seminal vesicle, adult	10201-103F3	149.73	20.10	7.94	6.88	3.17	0.53	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	81.38	30.85	4.13	2.67	1.70	0.49	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	55.61	15.85	3.52	0.00	0.50	0.75	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	56.20	18.06	3.01	3.01	3.01	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	56.41	20.15	3.36	3.90	3.90	3.36	1.07
signet ring carcinoma cell line:Kato III	10436-106E4	59.57	15.81	2.43	1.55	2.87	1.44	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	70.32	17.68	2.06	0.65	0.65	0.52	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	126.97	9.22	4.26	3.55	1.42	2.84	0.71
skeletal muscle, adult, pool1	10023-101D5	65.13	8.16	4.08	0.72	1.20	0.84	0.60
skeletal muscle, fetal, donor1	10066-101I3	43.22	3.02	1.01	1.01	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	101.78	0.00	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	119.93	18.31	1.89	8.84	1.89	0.00	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	71.71	12.34	2.33	3.00	4.00	2.33	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	129.86	53.27	3.47	13.87	6.93	3.78	2.52
small cell lung carcinoma cell line:DMS 144	10841-111E4	114.68	17.35	10.22	1.16	1.73	0.96	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	92.47	25.71	3.96	1.81	1.65	1.32	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	248.83	59.19	14.15	7.24	6.59	8.20	1.13
small cell lung carcinoma cell line:WA-hT	10562-108A4	73.22	21.36	3.27	4.79	3.70	2.62	0.44
small intestine, adult, pool1	10024-101D6	80.27	13.62	2.39	1.43	1.55	0.72	0.60
small intestine, fetal, donor1	10064-101I1	68.55	12.78	0.98	3.93	4.91	3.44	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	50.78	14.36	2.05	3.08	3.08	0.00	1.03
smooth muscle, adult, pool1	10048-101G3	89.17	10.60	5.43	5.43	2.07	3.36	1.03
somatostatinoma cell line:QGP-1	10781-110G7	49.05	7.24	1.88	1.61	1.34	0.27	0.54
spinal cord - adult, donor10196	10181-103D1	125.94	19.50	8.72	6.42	9.41	2.52	1.61
spinal cord, adult, donor10252	10159-103A6	149.43	19.71	5.13	7.49	1.97	1.97	0.39
spinal cord, adult, donor10258	10369-105F9	165.34	25.60	8.30	4.15	4.84	2.08	3.46
spinal cord, fetal, donor1	10056-101H2	110.99	15.86	3.66	4.27	0.00	0.61	0.61
spinal cord, newborn, donor10223	10359-105E8	115.26	33.52	4.13	4.59	2.30	3.21	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	47.49	6.87	1.94	1.05	1.05	1.49	0.45
spleen, adult, pool1	10025-101D7	79.63	12.00	1.98	1.65	0.88	1.10	0.33
spleen, fetal, pool1	10044-101F8	112.27	15.49	2.94	0.24	0.48	0.24	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	111.38	27.84	4.55	2.38	3.62	2.17	0.72
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	67.79	9.68	2.28	3.61	1.33	1.71	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	69.19	22.02	4.19	6.29	6.64	3.15	2.80
squamous cell carcinoma cell line:T3M-5	10616-108G4	74.67	28.54	4.30	1.17	1.17	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	85.77	21.16	6.53	3.04	2.93	4.05	0.56
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	79.21	8.05	2.97	0.85	1.27	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	65.15	15.23	1.27	0.42	1.27	1.27	1.27
stomach, fetal, donor1	10062-101H8	185.83	27.77	6.41	2.14	1.07	1.07	0.00
submaxillary gland, adult	10202-103F4	123.62	17.66	5.70	2.85	2.28	1.14	0.00
substantia nigra - adult, donor10196	10178-103C7	1302.58	379.92	108.55	759.84	434.19	379.92	54.27
substantia nigra, adult, donor10252	10158-103A5	112.16	13.29	4.36	12.05	6.02	2.28	1.66
substantia nigra, adult, donor10258	10371-105G2	109.14	20.69	6.21	4.66	2.07	2.07	1.55
substantia nigra, newborn, donor10223	10358-105E7	139.90	23.32	2.12	1.41	0.71	0.71	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	102.48	31.18	6.88	8.71	5.96	3.90	1.83
temporal lobe, adult, pool1	10031-101E4	70.27	9.16	7.38	0.51	1.10	0.25	0.51
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	199.43	27.07	12.11	13.53	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	198.67	30.77	7.03	6.59	0.00	1.32	0.00
tenocyte, donor1	11763-123H8	41.89	6.63	1.75	1.75	2.79	0.70	0.35
tenocyte, donor2	11765-123I1	28.99	6.10	0.76	1.53	1.14	0.76	0.76
tenocyte, donor3	11768-123I4	31.14	6.67	1.48	2.22	3.71	0.00	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	102.66	37.05	3.91	6.12	5.10	4.42	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	102.35	31.91	4.16	7.09	4.93	2.47	1.23
teratocarcinoma cell line:PA-1	10807-111A6	81.05	22.94	4.49	4.65	1.86	0.93	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	69.44	51.03	3.43	6.73	2.54	1.27	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	85.09	58.99	6.05	3.78	6.43	4.54	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	60.31	34.90	2.84	3.05	2.84	1.20	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	109.11	59.60	4.56	7.49	14.66	10.75	4.89
testis, adult, pool1	10026-101D8	75.81	15.57	5.15	0.54	2.58	1.18	0.21
testis, adult, pool2	10096-102C6	131.27	26.61	11.28	6.77	6.32	5.41	3.16
thalamus - adult, donor10196	10168-103B6	163.39	24.29	8.83	8.83	1.10	3.31	1.10
thalamus, adult, donor10252	10154-103A1	129.87	17.82	7.66	7.81	6.10	3.44	1.25
thalamus, adult, donor10258, tech_rep1	10370-105G1	157.04	21.55	6.16	3.08	0.00	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	79.05	11.03	4.28	2.96	1.32	1.48	0.66
thalamus, newborn, donor10223	10366-105F6	101.83	26.46	7.48	2.30	0.00	1.15	0.00
throat, adult	10209-103G2	136.07	17.98	3.99	2.50	0.25	0.25	0.00
throat, fetal, donor1	10061-101H7	101.47	21.33	5.79	3.96	3.96	0.61	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	132.95	63.40	1.99	3.18	2.19	1.59	0.40
thymus, adult, pool1	10027-101D9	125.36	25.75	2.09	1.19	2.19	1.19	0.80
thymus, fetal, pool1	10043-101F7	193.99	34.29	3.64	3.53	2.18	0.73	0.62
thyroid carcinoma cell line:KHM-5M	10776-110G2	82.70	22.07	3.06	1.73	0.93	0.66	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	74.04	17.04	3.63	6.43	4.33	2.37	0.84
thyroid, adult, pool1	10028-101E1	60.19	12.04	1.21	1.21	0.65	0.93	0.28
thyroid, fetal, donor1	10060-101H6	118.91	22.68	4.22	6.59	2.11	0.79	2.37
tongue epidermis (fungiform papillae), donor1	10288-104F9	147.82	18.48	9.24	9.24	0.00	3.08	0.00
tongue, adult	10203-103F5	84.89	12.33	3.02	3.26	3.02	1.86	1.40
tongue, fetal, donor1	10059-101H5	56.36	13.40	2.36	4.73	2.76	1.58	1.97
tonsil, adult, pool1	10047-101G2	127.82	18.63	3.31	1.00	1.20	0.30	0.30
trachea, adult, pool1	10029-101E2	75.83	9.49	1.96	0.74	1.47	1.23	0.16
trachea, fetal, donor1	10058-101H4	71.94	14.62	2.31	2.31	1.92	1.92	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	50.31	8.86	4.25	2.83	3.19	2.83	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	118.03	26.24	2.94	2.13	1.01	1.42	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	125.35	21.15	4.07	5.48	5.64	4.07	1.25
tridermal teratoma cell line:HGRT	10694-109G1	45.66	5.71	3.81	1.90	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	41.48	6.94	1.02	1.19	0.76	0.85	0.17
umbilical cord, fetal, donor1	10057-101H3	68.85	6.26	2.09	10.43	6.26	4.17	0.00
uterus, adult, pool1	10100-102D1	140.77	19.11	4.78	1.37	1.19	1.02	0.34
uterus, fetal, donor1	10055-101H1	81.40	17.41	1.02	3.58	3.07	3.07	0.51
vagina, adult	10204-103F6	85.94	11.63	1.94	2.58	0.00	0.65	0.65
vein, adult	10191-103E2	95.13	14.69	1.75	1.32	1.32	1.10	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	57.15	13.08	2.67	3.47	2.94	1.87	0.53